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1.  Introduction 
 
 
Breast cancer is the most common cancer to affect women worldwide 
and accounts for approximately 30% of new female cancer diagnoses (Siegel, 
Kimberly et al. 2017). The survival rates differ globally and have been 
reported to be almost double for the developed countries compared to 
developing ones (Coleman, Quaresma et al. 2008). This difference is mainly 
attributed to enduring improvement of screening mammography, helping in 
early detection of breast cancer. In breast cancer, cells lose their normal 
regulation and multiply uncontrolled invading adjacent tissues. Eventually, 
after leaving the initial location, these cells travel to different body parts (such 
as liver, brain, lung etc.), known as metastasis, which is substantially the 
cause of breast cancer mortality. There are several kinds of breast cancer, 
most frequently the infiltrating ductal carcinoma originating from the milk ducts 
of the breast. Other types of invasive breast cancer are the infiltrating lobular 
carcinomas, medullary carcinomas, mucinous carcinomas, tubular carcinomas 
and several more (Akram, Iqbal et al. 2017).  
 
 
 Epidemiology and risk factors 
A number of factors are associated with an increased risk of breast 
cancer, such as sex, age, affluence, family history, breast conditions and 
endogenous estrogens, as well as hormonal and lifestyle factors (National 
Breast and Ovarian Cancer Center 2009) (Table 1.1). More specifically, 
women have 100-fold higher risk to develop breast cancer compared to men 
(Thomas 1993) and the incidence increases with age . In addition, several 
genes have been identified that play a significant role in the risk of breast 
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cancer development, including BRCA1, BRCA2, TP53, PTEN and CHEK2 
gene, with mutations in these genes increasing the risk of breast cancer 
(Antoniou, Pharoah et al. 2003, Ghoussaini, Pharoah et al. 2013). 
Furthermore, giving birth to children reduces the risk of breast cancer about 
30% depending on the number of deliveries and on breastfeeding period 
compared to women without children (Marianne, W. et al. 1990, Kelsey, 
Gammon et al. 1993), probably due to changes in breast epithelial cells 
because of lactation. These cells seem to be less susceptible to DNA 
damage, preventing the development of cancer (Gadducci, Biglia et al. 2005).  
 
Table 1.1 Risk factors for breast cancer (adapted from Akhter et al. 2014). 
Factors Risk level 
Age Increase of risk, especially after 50 
Sex 100x fold for women than in men 
Age at menarche and menopause Increase of risk for menarche before 
14 and menopause after 54 
Age at first full pregnancy  Double risk if first child after 30 
3-fold increase without pregnancy 
BRCA1 / BRCA2 gene mutation 5x fold increase of risk 
High mammographic breast density Increased risk 
Diet and nutrition Increased risk after high intake of 
saturated fat 
Alcohol consumption Excessive intake 
Exposure to ionizing radiation Abnormal exposure in females after 
age of 10 
 
 
Interestingly, variations in nutrition and diet have attracted attention as 
possible evidence for the differences observed in breast cancer risk 
internationally. It has been suggested that the consumption of red meat 
(including beef, pork, lamb, goat, horse) increases the risk for carcinogenicity 
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(Bouvard, Loomis et al. 2015). Not only cancer, but also cardiovascular 
diseases and type 2 diabetes have been reported to be associated with long-
term consumption of processed red meat (Alisson-Silva, Kawanishi et al. 
2016). The role of red meat consumption in carcinogenesis has been 
attributed to compounds produced during cooking, such as heterocyclic 
amines and polycyclic aromatic hydrocarbons and others.  However, the same 
compounds are produced when cooking fish and poultry, the consumption of 
which is not associated with an increased risk of cancer (Alisson-Silva, 
Kawanishi et al. 2016).  
In addition to these studies, a new theory introducing a putative role of 
species-specific factors contributing to the etiology of certain diseases 
suggests that the consumption of red meat and dairy products originating from 
the species Bos taurus may explain a correlation with the global patterns of 
colon and breast cancer (zur Hausen and de Villiers 2015). According to the 
authors, in almost all high risk regions such us North America, most of the 
European countries and Australia, dairy cattle products are most consumed, 
while in low risk countries, such as Mongolia, Bolivia and India, we find 
different cattle species, such as Yak, Zebu and Zebu-Yak crossbreeds. This 
study also highlights the similarity in global incidence patters between colon 
and breast cancer (Figure 1.1). Yet, interesting differences are observed. 
More specifically, in India, breast cancer is increasing with higher rates 
compared to colon cancer and given that the Indian population does not 
consume beef meat, this increase could only be explained by the regular 
consumption of dairy products in recent decades, especially early in life. 
Furthermore, interesting differences are observed in Japan and Korea, where 
the milk consumption has been reported to increase after the Second World 
War and large quantities of beef meat were imported from the USA (zur 
Hausen and de Villiers 2015). Based on these observations, the authors 
suggested that dairy cattle may contain and transfer to humans a factor that is 
potentially involved in the development of breast and colon cancer, possibly 
as a result of various synergistic interactions (zur Hausen and de Villiers 
2015, zur Hausen, Bund et al. 2017). The same theory has been suggested to 
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apply to neurodegenerative diseases, such as Multiple Sclerosis and 
Parkinson’s disease, as well as to cardiovascular and autoimmune diseases. 
 
 
 
Figure 1.1 Global estimated incidence of colon (A) and breast cancer (B), 
GLOBOCAN 2012 (IARC). High risk regions for cancer incidence are shown 
in dark blue color and show similarity for the two types of cancer and the 
same applies for low risk counties indicated with light blue color. 
 
A population study in Sweden revealed significantly lower risk of breast 
cancer for individuals with lactose-intolerance compared to their lactose-
tolerant-parents and siblings. This was explained by the low consumption of 
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lactose-containing products of the lactose intolerant persons (Ji, Sundquist et 
al. 2015). 
The theory for a potential tumor virus present in beef products which is 
not destroyed by overcooking was confirmed to an extend by the recent 
isolation of three “hamburger “ polyomaviruses from beef samples purchased 
in supermarkets of San Francisco, USA (Peretti, FitzGerald et al. 2015). 
Following a well-established approach of virion enrichment, rolling circle 
amplification and next generation sequencing, they successfully detected 
three polyomavirus species, as well as an adenovirus and a herpesvirus, 
implicating that the presence of such viruses in meat would potentially affect 
human health.   
 
 
 Isolation of bovine meat and milk factors (BMMFs) 
The study of epidemiological data and speculations that were raised 
based on a potential role of virus-like agents in the development of cancer and 
other diseases led the group of Prof. de Villiers and Prof. Dr. zur Hausen into 
the analysis of bovine serum samples, commercially available milk, as well as 
human blood and tissue samples from Multiple Sclerosis patients. This study 
resulted in the isolation of 18 circular single-stranded DNA agents (Funk, 
Gunst et al. 2014, Gunst, Zur Hausen et al. 2014, Lamberto, Gunst et al. 
2014, Whitley, Gunst et al. 2014), which have been divided in four groups 
according to their nucleotide similarity to known DNA molecules (Figure 1.2). 
The isolates of Group 1 and Group 2 show similarity to Sphinx1.76 (acronym 
for Slow Progressive Hidden INfections of variable (X) latency) and 
Sphinx2.36 at the nucleotide level respectively. These represent episomes 
that have been isolated from brain and cultured neuronal cell lines of 
Creutzfeldt-Jakob disease (CKD) and sheep scrapie and show significant 
homology to Acinetobacter plasmids (Manuelidis 2011). Recently, the 
expression of the small Sphinx has been reported in neural cells and brain 
(Yeh, Gunasekharan et al. 2017). Due to the bovine origin of our Group 1 and 
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2 isolates, they have been called bovine meat and milk factors (BMMFs). 
Group 3 consists of isolates related to Gemycircularviruses, a group of single-
stranded DNA viruses infecting plants and mammalians (Male, Kraberger et 
al. 2016). The isolate of Group 4 is distantly related to a plasmid of 
Psychrobacter spec., which is found in a variety of sources (poultry, fish, sea 
water, clinical samples) and also as contaminants on complex media 
(reviewed in zur Hausen, Bund, and de Villiers 2017). 
 
 
Figure 1.2 Schematic view of the novel episomal circular DNAs isolated from 
milk, bovine serum and tissue and blood samples from MS patients (adapted 
from zur Hausen, Bund and de Villiers 2017).  
 
All isolates have an open reading frame (ORF) which encodes for a 
putative replication (Rep) protein and shares a high amino-acid similarity 
among the isolates (45-95%). The larger genomes include several additional 
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ORFs, the function of which is still under investigation. Furthermore, all 
isolates have an adenine and thymine (AT)-rich region and an iteron-like 
repeat region upstream of the rep protein, which is highly conserved, yet 
having single-nucleotide differences among them. These features are 
characteristic regions responsible for DNA replication initiation found in 
bacterial plasmids and eukaryotic replicons (Rajewska, Wegrzyn et al. 2012). 
The AT-rich region is located at the opening of the double helix where DNA 
synthesis starts. The iterons are responsible for binding the plasmid DNA 
replication initiator. The role of these complexes is important for the regulation 
and molecular mechanisms that are involved in replication.  
The MSBI1.176 Rep protein shows significant homology to replication 
initiator proteins of the Acinetobacter baumanii plasmids (Whitley, Gunst et al. 
2014). This bacterium is often related to nosocomial infections (Towner 2009). 
The presence of circular DNA in human brain, which is similar to an 
Acinetobacter plasmid, is an important observation that needs further 
investigation. Similar studies have already shown similarity of Acinetobacter  
to Sphinx2.36 (Longkumer, Kamireddy et al. 2013).  
In order to understand a potential role of BMMFs in the pathogenesis of 
certain diseases, it was important to investigate BMMF replication in human 
cells and their ability to be transcribed and translated. General transcription of 
all isolates tested this far has been demonstrated in HEK293TT cells, as well 
as a helper effect in the replication of MSBI1.176 after co-transfection with 
CMI1.252 (Eilebrecht, Hotz-Wagenblatt et al. 2018). The latest observations 
raised questions whether complementation of individual, yet similar agents, is 
possibly responsible for their pathogenic role in human. In addition, this study 
established the presence of antibodies against the MSBI1.176 Rep protein in 
plasma of healthy donors suggesting that there has been an exposure 
towards BMMF earlier in life. Furthermore, it was demonstrated that 
MSBI1.176 and CMI1.252 isolates differentially regulate several genes, which 
have been suggested to be involved in carcinogenesis or neurodegenerative 
diseases.  
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 Single-stranded DNA viruses 
Viral metagenomics have uncovered many novel types of single-
stranded DNAs (ssDNAs) and have expanded the environmental distribution 
of known viral groups (Rosario, Duffy et al. 2012, Simmonds, Adams et al. 
2017). Many ssDNA viruses identified through metagenomics encode a 
conserved replication-associated protein, so called circular Rep-encoding 
ssDNA viruses (CRESS-DNA viruses) (Rosario, Duffy et al. 2012). They 
belong to the families of plant pathogens Geminiviridae and Nanoviridae, but 
also to vertebrate pathogens like Anelloviridae, Parvoviridae and Circoviridae 
(Rosario, Duffy et al. 2012). During the last decade these viruses have been 
reported to be found in several environments including wastewater, sea 
waters, fecal samples, insects (Rosario, Schenck et al. 2015). The rapid 
evolution and high nucleotide substitution rates are characteristics of these 
viruses and have emerged as new taxonomic classification for this viral group 
(Figure 1.3).  
The vast majority of CRESS DNA viruses replicates through Rolling 
Circle Replication (RCR) (Rosario, Duffy et al. 2012). Briefly, the initiation in 
RCR requires nicking of the double-strand origin (dso) by Rep and generation 
of a 3’-ΟΗ end, where the host DNA polymerases start the leading strand 
replication. Subsequently, elongation includes entension of the 3’ terminus 
using the complementary strand as template. Once the viral strand is 
synthesized, Rep cleaves again at the reconstituted nick site and results in the 
formation of a new viral genome (Figure 1.4) (Rizvi, Choudhury et al. 2015, 
Ruiz-Maso, Macho et al. 2015) 
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Figure 1.3 Genetic diversity of CRESS-DNA viruses. Comparison of the Rep 
sequences of more than 600 CRESS-DNAs with 10 representative Rep 
sequences from viruses classified in the families Gemonoviridae, 
Geminiviridae, Nanoviridae and Circiviridae, and a group of alha satellites that 
are associated with geminiviruses or nanoviruses and representation with 
phylogenetic tree showing the similarity among the different viruses in amino 
acid level (Simmonds, Adams et al. 2017). 
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.  
(https://teaching.ncl.ac.uk/bms/wiki/images/thumb/7/78/RollingCircleReplication.jpg/800px-RollingCircleReplication.jp)   
Figure 1.4 Overview of rolling circle amplification. It starts with nicking of the 
double-strand origin (dso) by Rep and generation of a 3’-ΟΗ end, where the 
host DNA polymerases start the leading strand replication. Subsequently, 
elongation includes entension of the 3’ terminus using the complementary 
strand as template. Once the viral strand is synthesized, Rep cleaves again at 
the reconstituted nick site which results subsequently in the formation of a 
new viral genome. 
 
ssDNAs are often accompanied by subviral ssDNA molecules. 
Begomoviruses, for example, are associated with two major groups of satellite 
DNAs, which encapsidate and replicate with the help of the main virus, the 
alpha- and beta- satellites. The alpha-satellites can replicate autonomously, 
but they do not have a role in viral infection. Beta-satellites influence the 
pathogenicity of the virus by encoding a gene responsible for symptom 
development. In addition, there are reports of molecules smaller than 1 kb 
with unknown role, which are found in several types of viruses (Rosario, Duffy 
et al. 2012). Several reports document recombination events taking place 
between helper viruses and beta-satellites as well between alpha- and beta-
satellites (Huang, Xie et al. 2013), while similar events have been 
documented for herpes simplex virus (Vlazny and Frenkel 1981) and varicella-
zoster virus (Vlazny and Hyman 1985). Notably, the recombinant molecules of 
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approximately 700 nucleotides are capable of autonomous replication and 
interfere with the replication of the helper virus by defective interference.  
We speculate that the isolated agents (Figure 1.1) belong the family of 
CRESS-DNA viruses, since they share important characteristics such as the 
replication protein and the AT-rich region followed by four direct repeats up 
stream of the putative Rep ORF.  
 
 
 Viral infections & potential role of glycoproteins as receptors 
Readdressing the hypothesis that the consumption of red meat might act 
as potential risk factor for the development of cancer, a compelling theory has 
been recently suggested (Alisson-Silva, Kawanishi et al. 2016). According to 
these authors a new mechanistic model could explain the tendency for risk 
related to the consumption of red meat; they propose that the incorporation of 
the sialic acid N-glycolylneuraminic acid (Neu5Gc) into human membranes 
leads to an immune response. Sialic acids in general have an important role in 
cell-cell interactions and are the link between the cell and the extracellular 
environment. Neu5Gc cannot be synthesized in humans due to an exon 
deletion in the enzyme cytidine monophospho-N-acetylneuraminic acid 
hydroxylase (CMAH), which is responsible for the production of Neu5Gc by its 
ancestor sialic acid N-acetylneuraminic acid (Neu5Ac). Thus, Neu5Gc enters 
the human tissues only externally through the consumption of food rich in 
Neu5Gc, especially red meat and milk products. It has been reported that anti-
Neu5Gc antibodies appear during the first year of life (Taylor, Gregg et al. 
2010). Neu5Gc integrated into cellular glycoproteins and gangliosides might 
be targeted by circulating anti-Neu5Gc antibodies, causing chronic human 
inflammation (“xenosialitis”), which promotes carcinogenesis and supports 
cancer progression (Samraj, Laubli et al. 2014). The presence of anti-Neu5Gc 
antibodies found in sera from cancer patients suggest that they could serve as 
tumor biomarkers and ELISA tests sialoglycan microarrays could be used as 
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screening tools for assessment of persons at risk and for monitoring 
therapeutic response.  
A recent review summarizes why Neu5Gc glycoproteins might act as 
receptors for infection of BMMFs. Mainly, the authors report that it has already 
been demonstrated that several viruses bind specifically to Neu5Gc receptors, 
such as canine and fenine parvoviruses, polyomavirus type 9 and influenza 
and parainfluenza viruses. Furthermore, the authors highlight a potential 
relationship between anti-BMMF reactivity and Paul-Bunnell antibodies 
(Golaszewska, Kurowska et al. 2003), which recognize the Neu5Gc as 
immunogenic epitope in infectious mononucleosis, which has been reported to 
increase risk for Multiple Sclerosis (Haahr, Koch-Henriksen et al. 1995, 
Thacker, Mirzaei et al. 2006). In addition, they suggest that the conversion of 
Neu5Ac to Neu5Gc could potentially take place due to a Herpesvirus-specific 
O-glycosylating hydrolase and anti-BMMF reactivity could be increased after 
co-infection of cells with latently persistent BMMFs and EBV. Finally, anti-
Neu5Gc antibodies appear during the weaning period, which is also the time 
of potential exposure of humans during the weaning period to BMMFs through 
the consumption of commercially available milk and dairy products.  
 
 
 Viruses and breast cancer  
The role of viral infections in cancer development has been debated over 
decades. Nowadays, it is established that a number of viruses are responsible 
for carcinogenesis: human papillomaviruses (HPVs) 16 and 18, Epstein-Barr 
virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), hepatitis B 
virus (HBV), hepatitis C virus (HCV), Merkel Cell polyomavirus (MCV) and 
human adult T-cell leukemia virus type 1 (HTLV-1) (White, Pagano et al. 
2014). Research on the mechanisms of oncogenesis of these viruses is still 
ongoing and so far important knowledge has been gained. In general, 
oncogenesis can be generated a) by contribution of viral genes (e.g. HPV), b) 
by reduction of host immunity (e.g. human immunodeficiency virus, HIV) and 
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c) via chronic inflammation (e.g. HBV, HCV) (zur Hausen and de Villiers 2014, 
Gannon, Antonsson et al. 2018). However, the possibility of existence of yet 
unidentified agents or known ones for which no sufficient data exist at the 
moment and which might be associated with human cancer is under 
investigation.   
The identification of mouse mammary tumor virus (MMTV) in late 1930s 
fueled the discussion of a potential role of viruses in breast cancer. The key 
candidate viruses for breast cancer and eventually the most studied are HPV, 
EBV, MMTV and bovine leukemia virus (BLV). A number of studies supports 
an association between viral infections and breast cancer (Lawson and Heng 
2010, Glenn, Heng et al. 2012, Akhter, Ali Aziz et al. 2014, Lawson, Glenn et 
al. 2016, Nartey, Mazzanti et al. 2017, Lawson, Salmons et al. 2018). 
However,  when these data were reviewed by other scientists, they failed to 
support an oncogenic viral infection being involved in the causality of the 
disease and do not justify a conclusion that any of the viruses mentioned 
above have a valuable role in  the etiology of breast cancer. (Joshi and 
Buehring 2012, De Paoli and Carbone 2013, Akhter, Ali Aziz et al. 2014, 
Gannon, Antonsson et al. 2018). This debate might be a result of the relatively 
low abundance of viral DNA in human tissue and specifically within the final 
tumor, as well as the sample storage and preparation, potential laboratory 
contamination and the detection method used in each study.  
 
 
 Viral metagenomics 
Viral infections play a significant role in global health and the 
identification of novel pathogens is of great importance. During the last two 
decades, several outbreaks due to previously unknown viruses were reported, 
such the severe acute respiratory syndrome (SARS) coronavirus, the 
influenza H1N1 virus and the Ebola virus (Chiu 2013). Traditional methods of 
viral discovery included propagation of the virus in cell culture, serology or 
polymerase chain reaction (PCR) using consensus primers and hybridization 
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methods. However, these approaches require a priori knowledge of the 
identity of the infectious agent and have little or no value in identifying novel 
viruses. This led the researchers to “metagenomics”, an approach that does 
not require any prior knowledge about the investigating organisms 
(Handelsman 2004). The sequence-independent techniques includes random 
amplification techniques, such as the rolling circle amplification (RCA), which 
has been used in the detection of circular DNA viruses such as 
polyomaviruses, papillomaviruses and circoviruses (Niel, Diniz-Mendes et al. 
2005, Schowalter, Pastrana et al. 2010, van der Meijden, Janssens et al. 
2010, Dela Cruz, Giannitti et al. 2013), as well as the sequence-independent 
single-primer amplification (SISPA), which was used in the identification of 
Hepatitis E virus, Norwalk virus, Human astrovirus and Parvoviruses 2 and 3 
(Mokili, Rohwer et al. 2012).  
Next Generation Sequencing can be used for complete genome 
resequencing for mutation discovery in human genomes, transcriptome and 
small RNA sequencing for gene expression, alternative splicing and 
microRNA profiling, chromatin immunoprecipitation sequencing (ChIP-Seq) for 
mapping of protein-DNA interactions and sequencing of bisulfite-treated DNA 
for cytosine methylation in genomic DNA (Shendure and Ji 2008).  
Three are the main steps involved in metagenomic analysis: a) sample 
preparation, b) high-throughput sequencing and c) bioinformatic analysis 
(Mokili, Rohwer et al. 2012). 
 
 
a) Sample preparation 
Detection sensitivity for the identification of novel pathogens depends on 
the reduction of the host background and the physical enrichment of the virus 
particles. Purification of virus capsid, filtration, ultracentrifugation and 
digestion with DNase digestion, as well as enrichment methods such as the 
RCA and the SISPA are often used for enrichment and degradation of host 
genomes (Mokili, Rohwer et al. 2012, Chiu 2013). 
  Introduction 
22 
 
  
b) High-throughput sequencing  
The selection of parameters in the sequencing platform is of critical 
importance in the detection of novel viruses. The generation of long sequence 
reads permits the generation of long contigs in de novo assembly, increasing 
the possibility of identification of sequences that correspond to unknown 
viruses. Furthermore, there must be sufficient generated reads for adequate 
sequencing depth (Tang and Chiu 2010, Chiu 2013).  
 
c) Bioinformatic analysis  
The key steps in analysis of the data obtained from NGS include the 
quality assessment and the removal of low-quality sequences (low quality 
corresponds to accuracy of base calling, it is filtered by Q score and a Q score 
of 30 refers to a base with a 1 in 1000 probability of being incorrect  (Cliften 
2015)) and host DNA, followed by either mapping to a known genome, which 
acts as reference, or by de novo (reference-free) assembly, which allows non-
overlapping regions to be combined into one consensus sequence (Mokili, 
Rohwer et al. 2012). The generated contigs are then compared to the 
GenBank using Basic Local Alignment Search Tool (BLAST) (Datta, 
Budhauliya et al. 2015). 
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Aim of the thesis 
 
Small circular DNA genomes have been isolated from cow milk, bovine 
serum and blood and tissue samples from Multiple Sclerosis patients (Funk, 
Gunst et al. 2014, Gunst, Zur Hausen et al. 2014, Lamberto, Gunst et al. 
2014, Whitley, Gunst et al. 2014, Falida, Eilebrecht et al. 2017). Additionally, 
epidemiological data point at a relation between the consumption of milk and 
red meat and an increased incidence of certain types of cancer, such as 
colon, breast and prostate cancer as well neurodegenerative diseases like 
Parkinson’s disease and Multiple Sclerosis. However, little is known about the 
potential role of the above-mentioned isolates during the development of such 
diseases.  
The main aims of this study were: 
1. to expand the work previously done regarding the isolation of episomal 
DNA agents from cow milk to different dairy products (e.g. yogurt, 
crème fraiche, card cheese, butter). 
 
2. to identify novel episomal DNA agents as well as agents related to the 
already identified molecules in breast cancer tissue samples, using 
Next Generation Sequencing (NGS) of DNA. 
 
3. to search for a permissive cell system for the identified bovine milk and 
meat factors (BMMFs). Epidemiological data suggest a potential link 
between the consumption of red meat and animal exposure and the 
incidence of Hodgkin’s disease (Khuder, Mutgi et al. 1999, Epstein, 
Chang et al. 2015), while in the past 24 full-length Torque Teno viruses 
(a single stranded DNA virus) have been isolated from a single patient 
with Hodgkin’s lymphoma (Jelcic, Hotz-Wagenblatt et al. 2004). 
Therefore, two Hodgkin’s lymphoma cell lines, the L-428 and L-1236, 
were selected for transfection with the MS brain isolate MSBI1.176 and 
they were analyzed regarding the replication of the genome. In 
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addition, co-transfection experiments with two different genomes were 
performed in order to test for a helper or interfering effect over 
replication, since it has already been reported that while replication of 
MSBI1.176 was abortive in HEK293TT cells, co-transfection with 
CMI1.252 (cow milk isolate) resulted in almost stable MSBI1.176 
replication until 14 days post transfection. In addition, it has been 
reported that incorporation of N-Glycolylneuraminic acid (Neu5Gc) into 
glycoproteins of human cells leads to chronic inflammation which 
potentially promotes cancer and other diseases (Alisson-Silva, 
Kawanishi et al. 2016). In order to test an involvement of Neu5Gc in the 
permissiveness of human cells for BMMFs and establish an infection 
system for BMMFs, infection assays were performed using MSBI1.176 
positive supernatants of MSBI1.176-transfected cells with and without 
addition of external Neu5Gc. 
 
4. to analyze a potential link of BMMFs to breast cancer or to Hodgkin’s 
disease etiology and to assess a potential immunological response to 
those agents, specifically in patients suffering from the respective 
disease. In the latter case, elevated antibody titers directed against 
BMMF gene products in sera of disease patients would be expected 
compared to healthy controls. Therefore, sera from breast cancer and 
Hodgkin’s disease patients were analyzed by ELISA assays in order to 
identify a potential immune reaction of those patients against the Rep 
protein of MSBI1.176.  
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2.  Materials and Methods 
 
2.1  Chemicals 
All chemicals were purchased from Merck (Darmstadt), Thermo-Fischer 
Scientific (Germany), Sigma-Aldrich (USA), Carl Roth (Karlsruhe), Gerbu 
Biotechnik (Heidelberg), Fisher Chemical (Loughborough) and QIAGEN 
Sciences (USA) in molecular biology grade, except where otherwise specified. 
Disposables were purchased from Greiner Bio-One (Germany), nerbe plus 
(Germany) and Eppendorf (Germany). 
 
2.2  Enzymes, reagents and kits 
Table 2.1 List of enzymes, reagents and kits. 
PRODUCT VENDOR 
96-well MaxiSorpTM ELISA plates Thermo Scientific 
Agilent DNA 12000 Kit Agilent Technologies 
AmpliTaq Gold DNA Polymerase with Gold 
Buffer and MgCl2 
Applied Biosystems, Thermo 
Fisher Scientific 
CellTiter-Glo® Luminescent Cell Viability 
Assay 
Promega 
ClarityTM Western ECL Substrate Bio-Rad 
Click-iTTM Edu Plus Alexa FluorTM 647 
Imaging Kit 
Thermo Scientific 
dNTP Mixture  Takara Bio Inc. 
Exo-Resistant Random Primer Thermo Scientific 
FastAP Thermosensitive Alkaline 
Phosphatase (1 U / µl) 
Thermo Scientific 
GeneRulerTM DNA Ladder Mix, ready-to-use Thermo Scientific 
Glycogen Invitrogen, by life Technologies 
NEB 5-alpha Competent E. coli cells New England BioLabs 
N-glycolylneuraminic acid (Neu5Gc) Sigma Aldich 
Nucleofector® Kit V LONZA 
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PfuUltra II Hotstart PCR Master Mix, 100 rxn Agilent Technologies 
phi29 DNA Polymerase New England BioLabs 
phi29 DNA Polymerase Reaction Buffer 
Pack  
New England BioLabs 
Plasmid-SafeTM ATP-Dependent DNase Epicentre® Technologies 
Proteinase K  
RestoreTM PLUS Western Blot Stripping 
Buffer 
Thermo Scientific 
Restriction enzymes Thermo Scientific 
Restriction enzymes New England BioLabs 
Skim milk powder GERBU Biotechnik 
Superblock® T20 (PBS) Buffer Thermo Scientific 
SYBR Green PCR Master Mix Applied Biosystems, Thermo 
Fisher Scientific 
T4 DNA Ligase, 5 Weiss U/µl Thermo Scientific 
T4 Polynucleotide Kinase with Buffer New England BioLabs 
TA Cloning® Kit with One Shot® TOP10F´ 
Chemically Competent E.coli 
Invitrogen 
TaKaRa LA Taq® with GC Buffer Takara Bio Inc. 
TMB ELISA Substrate Kit Thermo Scientific 
Trans-Blot® TurboTM Transfer System Bio-Rad 
TruPAGE SDS Running Buffer, 20x Sigma Aldrich 
TruPAGETM Precast Gels 4-20% Sigma Aldrich 
Trypan Blue Solution, 0.4% Thermo Scientific 
Venor®GeM Classic Minerva Biolabs 
 
Enzymes were used according to the manufacturer’s protocol. DNA 
extractions from tissue samples and cultured cells were performed with 
DNeasy Blood & Tissue Kit (QIAGEN), QIAamp® DNA Blood Mini Kit 
(QIAGEN), QIAprep® Spin Miniprep Kit (QIAGEN) and Plasmid Mini AX kit 
(A&A Biotechnology). Cell lysate homogenization for RNA isolation was done 
with the QIAshredder homogenizer (QIAGEN). For DNA extraction from 
agarose gels and PCR clean-up the NucleoSpin® Gel and PCR Clean-Up kit 
(MACHEREY-NAGEL) was used. Plasmid DNA purification from transformed 
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bacteria was done with the NucleoBond® Xtra Midi kit (MACHEREY-NAGEL) 
and the AccuPrep® Plasmid Mini Extraction Kit (BIONEER Corp.).    
 
2.3  Synthetic oligonucleotides 
All primers for polymerase chain reactions and sequencing were purchased 
from Sigma-Aldrich.  
 
Table 2.2 List of primers used for PCR and qPCR. 
PCR   
Primer name Forward (5´ 3´) Reverse (5´ 3´) 
7717N_cont_80_
16 
AATGTGGCAAAAGGCGTTAC GTGACCCATTCGTACTGCTTG 
AL_CQ 3p 
AL_CQ 5p 
CTTCTAGGTTATAACTTGCATTA TCACAGAACAACGACTAATTC 
Bc_con 3p  
Bc_con 5p 
ATTGATTAAAGCATTATCTTT GCCAGTTATAACCTAGA 
Dx 3p 
Dx 5p 
ATTCCAAGTTATAACTGGCATTG TAACAGAACAGCGTTTGATTAT
G    
FU_BF 3p  
FU_BF 5p 
GGTCTAGGTTGTAGCTCG TAGTGGAACAACGTTTGATTC 
LF271 
LR2249  
ATTGCCCCTCGACTAAGCAAGC  
 
TGTACGAAAGCTAGCACCACCG 
 
M1sg613 AGATGCGAGTTATTGAATTAG CTAAGCAAGCTTAGTCGAG 
mtDNA sense 
mtDNA antisense 
ACCACCTCTTGCTCAGCCTA CATGGGCTACACCTTGACCT 
mt2DNA sense 
mt2DNA 
ACACTCATCGCCCTTACCAC GTTGATGCAGAGTGGGGTTT 
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antisense 
mt3DNA sense 
mt3DNA 
antisense 
GCTAAACCTAGCCCCAAACC TTGGCTCTCCTTGCAAAGTT 
mt4DNA sense 
mt4DNA 
antisense 
TATCCGCCATCCCATACATT GGTGATTCCTAGGGGGTTGT 
Oa 
Ob 
CTAGACGAGTTTAGAAAGCG 
 
CTCAATAATTGGTGTTTTGCC 
 
Oc 
Od 
ACCAATTATTGAGCTAGACGAG 
 
GTTTTGCCTGTGCTACGCC 
 
Oe 
Of 
GCACGAGTGGGTTACATCG 
 
ACCCAACTGATCTTCAGCATCT 
 
pNLF1-N sense 
pNLF1-N 
antisense 
CAGGGAGGTGTGTCCAGTTT 
 
GCCATAGTGCAGGATCACCT 
 
pUC19 ACCGGAGCTGAATGAAGCCATA
CC 
TCCCAACGATCAAGGCGAGTTA
CA 
pUC19 sense 
pUC19 antisense 
AGTTGGCCGCAGTGTTATCA 
 
TCCTTGAGAGTTTTCGCCCC 
 
sg613.L4.7/F,R 
sg613.L4.9/R 
TAGATACTGAATACCCCTACG 
 
CGTAGGGGTATTCAGTATC 
 
CGTAGGGGTATTCAGTATCTA 
Nn (Sphinx 1.76)  
Xn (Sphinx 1.76) 
GGATTAATGCCAATGATCC 
 
CTTTGCCTGTTTCTCTCG 
 
No (Sphinx 1.76) 
Xo (Sphinx 1.76) 
GAGGACGAATTAATATTACAAGT
C 
 
GTTCTCGCTTTTCTTGGTAA 
 
qPCR   
beta actin gene 
sense 
 
CCACCATGTACCCTGGCATT ATCTGAGGAGGGAAGGGGAC 
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beta actin gene 
antisense 
  
CMI1.252-specific 
sense 
 
CMI1.252-specific 
antisense 
ACAAGCTAGAAGAATTTGGCGT
G 
 
TGGCACAGTAGAGCTTTCATCA 
 
MSBI1.176 lin/circ 
sense 
 
MSBI1.176 
lin/circ antisense 
ACCCCTACGTTTACCTTGCG 
 
CCTTTGCCTGTTTCTCTCGC 
 
MSBI1.176-DpnI 
sense 
 
MSBI1.176-DpnI 
antisense 
CCCACACAGCAAGGCATACA 
 
 
CCTTTGCCTGTTTCTCTCGC 
 
MSBI1.176-
specific sense 
 
MSBI1.176-
specific antisense 
ACGGGTAGGCTTGCTTATTTGA 
 
TGTATGCCTTGCTGTGTGGG 
 
 
pUC19 sense 
pUC19 antisense 
AGTTGGCCGCAGTGTTATC TCCTTGAGAGTTTTCGCCCC 
pUC19-specific 
sense 
 
pUC19-specific 
antisense 
GCTCAGTGGAACGAAAACTCAC 
 
AGCCCTCCCGTATCGTAGTT 
 
 
 
 
2.4  Plasmids & DNA genomes 
Table 2.3 Vectors used and their application. 
Vector Application Vendor 
pCR2.1  Standard cloning of PCR products Invitrogen, by life Technologies 
pUC19  Sub-cloning of restriction-digested 
DNA fragments  
New England Biolabs 
pcDNATM3.1 (-) Cloning of proteins for over-
expression  
Invitrogen 
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pNLF1-N  Control in protocol establishment for 
isolation of plasmid DNA from human 
tissue 
Promega 
pZsGreen Transfection efficiency control Clontech 
pmaxGFP® Transfection efficiency control LONZA 
 
 
Table 2.4 DNA genomes from the lab mentioned in the Results part. 
Genome Full name Accession Number 
(GenBank) 
CMI1.252 Cow Milk Isolate 1 LK931487 
CMI2.214 Cow Milk Isolate 2 LK931488 
CMI3.168 Cow Milk Isolate 3 LK931489 
CMI4.158 Cow Milk Isolate 4 LK931490 
CMI5.170 / CMI5.240 Cow Milk Isolate 5 LT715554,  LT715555 
HCBI3.108 / HCBI4.296 
HCBI5.173 / HCB1.6.159 
HCBI6.252 
Healthy Cow Blood Isolate 3,4,5,6 LK931495,  LK931496 
LK931497, LK931494 
LK931493 
MSBI1.176  Multiple Sclerosis Brain Isolate 1 LK931491 
MSBI2.176 Multiple Sclerosis Brain Isolate 2 LK931492 
 
 
2.5  Standard media (E. coli) 
LB (Luria Bertani): 0.5% (w/v) tryptone  
1% (w/v) yeast extract  
0.5% (w/v) NaCl in sterile water.  
   After autoclaving ampicillin (100 µg / ml) was added.  
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For preparation of media plates the LB medium was supplemented with 1% 
agar and sterilized. 0.2% X-Gal and 0.2% IPTG were added and after mixing, 
the plates were poured.  
 
 
2.6    Standard solutions and buffers 
Chloroform:Isoamyl alcohol 24:1 (CIA) 240 ml Chloroform 
      10 ml Isoamyl alcohol  
 
TE 1x:      10 mM Tris base 
1 mM EDTA  
pH 8 
 
2x PK Buffer     0.2 M Tris-HCl, pH 7.5 
      25 mM EDTA  
      0.3 M NaCl  
      2% SDS 
 
Proteinase K dilution    20 mg / mL in sterile water 
3 M sodium acetate solution pH 5.2  40.8 g sodium acetate  
          pH 5.2  
In a final volume of 100 ml   
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Ammonium acetate 7.5 M:   57.81 g ammonium acetate / 100 ml
          
1 x EP Buffer:    40 mM Tris Base 
      5 mM sodium acetate 
      1 mM EDTA 
      pH 7.8 
DNA loading dye:    0.5% Orange G 
      50% glycerol 
 
Freezing medium:  17% RPMI-1640 Medium with L-glutamine and 
    sodium bicarbonate 
    20% FCS 
    10% DMSO  
 
5 x Lämmli Buffer    250 mM Tris-HCl pH 6.8 
      8% SDS 
      30% glycerol  
      0.2% bromophenol blue 
 
2.5 Lämmli buffer    4.5 ml 5 x Lämmli 
      4.5 ml sterile H2O 
      1 ml 2-Mercaptoethanol 
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ELISA reagents 
Coating buffer: PBS 8M Urea  8 M Urea  
      100 mM NaH2PO4x2H2O 
      10 mM Tris-HCl pH 8  
      In a final volume of 500 ml 
 
 
Wash buffer: PBS/Tween   1 x PBS pH 7.2 
      0.1% (v/v) Tween 20 
 
Stop solution     1 M sulfuric acid 
      8 M acetic acid   
 
 
Western blot reagents 
Ponceau Staining Solution   0.5% (w/v) Ponceau S 
      1% acetic acid 
 
Blocking buffer    5% (w/v) skim milk powder  
      1xPBS 
 
Washing buffer    0.1% Tween 20 
1xTBS 
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TBS 1x     150 mM NaCl  
      20 mM Tris-HCl  
      pH 7.6 
In a total volume of 1 L  
  
 
   
2.7 Softwares / web interfaces 
 
HUSAR (Heidelberg Unix Sequence 
Analysis Resources) 
Web site: 
https://www.dkfz.de/gpcf/hs_husar.html 
NEBtoolsTM Tm Calculator Web site: 
http://tmcalculator.neb.com/#!/main 
Primer BLAST (NCBI) Web site: 
https://www.ncbi.nlm.nih.gov/tools/primer-
blast/ 
Quantity One 1-D Analysis 4.6.9 Bio-Rad 
GIMP 2.8.22 GIMP 
Image LabTM Software 5.2.1 Bio-Rad 
QuantStudioTM Design & Analysis 
Software v1.4 
Applied biosystems, ThermoFisher 
Scientific 
Clone Manager v6 Sci-Ed Software 
SigmaPlot 13.0 Systat Software Inc. 
PuTTY 0.70 PuTTY 
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2.8 Molecular Biology Methods 
2.8.1 Phenol-isoamyl-chloroform extraction of DNA & ethanol 
precipitation 
For the lysis step 12 ml of the sample, 12 ml 2 x PK Buffer and 500 µl 
Proteinase K dilution were added in a 50 ml falcon and the mixture was 
rotated overnight at 37 oC. Subsequently, the sample was mixed with 1 
volume of phenol for 20 min and centrifuged at 5000 rpm for 15 min at room 
temperature. The aqueous phase was transferred to a fresh falcon tube and 
the previous step was repeated. The aqueous phase was transferred to a 
fresh falcon tube and mixed with ½-volume phenol and ½-volume CIA for 20 
min, followed by centrifugation at 5000 rpm for 15 min at room temperature. 
The aqueous phase was transferred to a fresh falcon tube, mixed with 1 
volume CIA for 20 min and centrifuged at 5000 rpm for 15 min at room 
temperature. The aqueous phase was transferred to a fresh tube and 2 
volumes of absolute ethanol,      of the volume of 3 M sodium acetate 
solution and 1 µl glycogen were added. For DNA precipitation the mixture was 
incubated for at least 2h at -20 oC. Consequently, the mixture was centrifuged 
for 45 min at 12000 rpm at 4 oC, the supernatant was discarded and the pellet 
was rinsed with 70% ethanol. Centrifugation was repeated once and the DNA 
pellet was air-dried and dissolved in an appropriate volume of TE buffer. 
 
 
2.8.2 Purification of extracted DNA 
For the purification of the isolated DNA, the NucleoSpin® Gel and PCR Clean-
Up kit (MACHEREY-NAGEL) was used following the manufacturer’s protocol 
for PCR clean-up. The elution step was repeated 3 times with 30 µl NE buffer 
heated at 70 oC.  
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2.8.3 Rolling circle amplification (RCA) 
Rolling Circle Amplification by the phi29 DNA Polymerase was used to 
specifically amplify circular DNA molecules. For the RCA the phi29 DNA 
Polymerase Reaction (New England BioLabs) was used according to the 
following protocol:  50 ng total DNA were placed into a PCR tube containing 
1x phi29 DNA Polymerase Reaction Buffer, 50 µM Exo-Resistant Random 
Primer (Thermo Scientific), 0,01 mg BSA and the total volume was adjusted 
with H2O to 10 µl. The mixture was heated to 95 
oC for 3 min and cooled to 
room temperature. The reaction was brought to a final volume of 20 µl 
containing 1x phi29 DNA Polymerase Reaction Buffer, 0.004 mg BSA, 0.4 
mM dNTP Mixture (Takara Bio Inc.) and 10 U phi29Pol (New England 
BioLabs) and it was incubated at 30 oC for 18 h followed by 10 min incubation 
at 65 oC.  
 
2.8.4 Polymerase chain reaction (PCR) 
A standard PCR was perfomed using the TaKaRa LA Taq® in 1x GC Buffer 
(Takara Bio Inc.) in a final volume of 50 µl containing 100-200 ng DNA 
template, 10 µM of each primer (forward and reverse), 8 µl dNTP mix (2.5 mM 
each) and 2.5 U LA Taq®  Polymerase. The reaction was run in a 
thermocycler according to the protocol bellow (Table 2.5). 
Table 2.5 Standard PCR amplification program. 
Time Temperature Step  
1 min 95 oC denaturation  
30 sec 95 oC denaturation  
1 min Tm - 5 
oC annealing 30-40 x 
    1 - 4 min 72 oC elongation  
10 min 72 oC final extension  
  
For proof reading PCR, proof reading DNA polymerase (PfuUltra II Hotstart PCR 
Master Mix, 100 rxn, Agilent Technologies) was used in order to certify definite 
amplification. 
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2.8.5 Agarose Gel Electrophoresis 
DNA was analyzed by agarose gel electrophoresis based on the molecular 
weight / electro mobility. 1/6 volume of loading dye was mixed with each 
sample and run on a 1 - 2.5% (w / v) agarose gel. The agarose percentage 
was adjusted according to the size of the DNA fragments to be separated. 
The gel was prepared in 1x EP buffer, which was also used as running buffer. 
The gel was run at 90 V. The size was estimated based on the GeneRulerTM 
DNA Ladder Mix, ready-to-use (Thermo Scientific) (Fig. 2.1). The gel was 
stained in 1x EP buffer containing ethidium bromide for at least 15 min and 
stained DNA fragments were visualized by UV-light.  
 
Figure 2.1 DNA ladder for agarose gel electrophoresis (GeneRulerTM DNA 
Ladder Mix, ready-to-use, Thermo Scientific). 
 
2.8.6 DNA extraction from agarose gels 
For subcloning or further processing, DNA fragments were extracted from 
agarose gels after electrophoresis. Therefore, the desired band was cut with a 
scalpel under UV-light. For the extraction of DNA, the NucleoSpin® Gel and 
PCR Clean-Up kit (MACHEREY-NAGEL) was used according to the 
manufacturer’s protocol.  
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2.8.7 Ligation of DNA fragments 
2.8.7.1    Ligation with the TA cloning kit (Invitrogen)  
DNA fragments obtained from PCR using the Taq DNA polymerase contained 
a TA overhang which made them suitable for subcloning with the TA Cloning® 
Kit (Invitrogen). The amount of extracted DNA insert used for ligation with 50 
ng of pCR2.1® vector was calculated based on the equation: 
X ng insert = 
(           )(  ⁄                      )
(                                 )
, 
where X ng is the amount of the DNA isert to be ligated and Y is the number of base 
pairs of the insert for a ratio of 1:3 (vector:insert) (adapted from TA Cloning® kit, User 
manual). 
For a standard ligation reaction in a total volume of 10 µl, the manufacturer’s 
instructions were followed. 
 
2.8.7.2   Ligation with other vectors 
For the ligation of DNA fragments in vectors other than the pCR2.1, a 5´-
dephosphorylation step of the linearized vector was preceded in order to 
avoid religation of the vector. Therefore, 2 U FastAP (Thermo Scientific) were 
added directly after restriction digestion with the corresponding enyzme and 
the mixture was incubated at 37oC for 15 min, followed by a 5 min incubation 
at 75oC. The insert DNA was restricted with the same restriction enzyme and 
purified from an agarose gel (see 2.7.6), before the ligation reaction was 
started. 
The ligation was performed overnight at room temperature using the T4 DNA 
ligase (Thermo Scientific) in a final volume of 50 µl in 1x T4 DNA ligase buffer. 
The amounts of vector and DNA were calculated according to the equation 
shown in 2.7.7. The enzyme was inactivated by 15 min incubation at 65oC. 
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2.8.8 Transformation of competent E. coli cells 
The One Shot® TOP10F´ chemically competent E.coli cells have been used 
for transformation of palsmids containing subcloned vectors, unless it is 
indicated differently. The transformation was performed according to 
manufacturer’s instructions and the cells were plated on LB Medium plates 
containing IPTG, X-Gal and Ampicillin. They were incubated overnight at 
37oC. 
 
2.8.9 Plasmid DNA isolation from E. coli cells 
Starter bacteria cultures were inoculated by single colonies obtained after 
transformation and cultured overnight at 37 oC on a shaker at 130 rpm. The 
AccuPrep® Plasmid Mini Extraction Kit (BIONEER Corp.) was used for 
plasmid DNA purification according to manufacturer’s protocol. The final 
elution volume was 50 µl. For midi scale plasmid preparations, the 
NucleoBond® Xtra Midi kit (MACHEREY-NAGEL) was used according to 
manufacturer’s instruction. Therefore, cultures of 400 ml inoculated with a 
1:1000 dilution of the corresponding starter cultures were incubated overnight 
at 37 oC on a shaker at 150 rpm. The isolated plasmid was dissolved in an 
appropriate volume of TE buffer. The amount (A260) and purity (A260 / A280) of 
the isolated DNA were measured on a UV Spectrophotometer.  
 
2.8.10 DNA restriction enzyme digestion 
For subcloning of DNA fragments and verification of generated plasmid DNAs, 
DNA was restricted using restriction endonucleases. Therefore, the desired 
amount of DNA was digested at 37oC by the appropriate amount of restriction 
enzyme, which was determined by the equation: 
 
 
 
  
  
 
  
  
    , 
 where  U = Units of enzyme 
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  h = hour 
  LR = size of reference genome (  = 48.5 kb) 
  Lv = size of DNA of interest 
  Nv = number of restriction sites in DNA of interest  
  NR = number of restriction sites in reference genome 
  mv = mass of DNA of interest  
 
2.8.11 Sequencing of plasmid DNA 
The sequence of the isolated plasmids was determined by Sanger 
Sequencing from the GATC Biotech company. For a sequencing reaction, a 
total volume of 30 µl purified DNA with concentration of 50-70 ng / µl were 
used. The obtained sequences were analyzed using the HUSAR platform and 
the Clone Manager software (see 2.6).  
 
 
2.8.12 Sub-cloning of pCR®2.1cloned genomes into pUC19 
For transfection experiments, it was necessary to prepare circularized BMMF 
genomes lacking the residual vector fragments. The corresponding DNA had 
to transferred from pCR2.1 vector into the pUC19 vector bz using a unique 
restriction site present in both the BMMF genome and the multiple cloning site 
if the pUC19 vector. Therefore, the full pCR2.1-cloned BMMF genome was 
first amplified bz PCR using the same primers as for cloning into the pCR2.1 
(NnXn primers, see Appendix). The PCR reaction was performed with 100 ng 
DNA template using the program shown in Table 2.6. 
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Table 2.6 PCR program for sub-cloning of pCR®2.1clone genome into 
pUC19.    
Time Temperature Step  
2 min 95 oC denaturation  
45 sec 95 oC denaturation  
45 sec 58 oC annealing   x 35 cycles 
 1,5 min 72 oC elongation  
7 min 72 oC final extension  
 
Immediately after PCR, the DNA template was digested with 25 U DpnI for 2 h 
at 37 oC. After agarose gel electrophoresis (see 2.7.5.), the band of interest 
was cut, extracted (see 2.7.6) in 45 µl sterile water followed by a 
phosphorylation step in 1x Polynucleotide Kinase Buffer (New England 
Biolabs) using 10 U T4 Polynucleotide Kinase (PNK, New England Biolabs) 
for 1 h at 37 oC. After inactivation of the PNK at 65 oC for 15 min, the DNA 
was purified by addition of 500 µl extraction equilibration buffer of the 
NucleoSpin® Gel and PCR Clean-Up kit (MACHEREY-NAGEL) and according 
to the manufacturer’s instructions. Next, the resulting blunt-end DNA fragment 
was circularized by self-ligation. The self-ligation was performed with the full 
amount of purified DNA using 10 U T4 Ligase (Thermo Scientific) in 1x T4 
ligase buffer in a final volume of 40 µl and overnight incubation at room 
temperature. Subsequently the sample was subjected to RCA (see 2.7.3) 
followed by overnight restriction digestion at 37 oC with the appropriate 
restriction enzyme in a final volume of 80 µl (see 2.7.10). 2 µg of pUC19 
vector were also linearized with the same enzyme in a total volume of 20 µl. 
After agarose gel electrophoresis (see 2.7.5), the restricted RCA product was 
cut and extracted from the gel while 2 µl of the pUC19 linearized mixture were 
added during gel extraction. The DNA was extracted in 40 µl sterile water 
followed by overnight ligation with 10 U T4 Ligase (Thermo Scientific) at 37 
oC. The enzyme was inactivated by a 15 min incubation at 65 oC. The 
resulting ligation product was used for transformation of chemically competent 
bacteria (see 2.7.8) followed by standard mini plasmid preparation (see 2.7.9) 
and sequencing (see 2.7.11). 
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2.8.13 Preparation of circularized genomes 
For the generation of large amounts of circularized BMMF genomes for cell 
culture transfetcions, 250 µg pUC19-cloned BMMF genome were digested 
overnight at 37 oC with the appropriate restriction enzyme used for cloning in 
a total volume of 500 µl of the corresponding buffer (see 2.7.10). After 
agarose gel electrophoresis (see 2.7.5), the band of interest was cut, 
extracted and eluted from the gel (see 2.7.6). 50 µg of the linear BMMF DNA 
were ligated using 30 U T4 Ligase (Thermo Scientific) in 1x T4 DNA Ligase 
Buffer (Thermo Scientific) in a total volume of 9 ml at 16 oC for >50 h.  4.5 ml 
ammonium acetate (7.5 M) and 35 ml 95% ethanol were added before mixing 
for overnight precipitation of the genome at 4 oC. After 1h centrifugation at 
5000 rpm and 4 oC, the DNA pellet was rinsed with 70% ethanol and 
dissolved in an appropriate volume of TE buffer. The efficacy of the self-
ligation was tested by restriction digestion with two different restriction 
enzymes.  
2.8.14 Quantitative PCR (qPCR) 
qPCR analyses were performed on a QuantStudioTM 5 System instrument 
type (Applied Biosystems) with default conditions according to manufacturer’s 
insructions for 96-Well block type with standard curve and SYBR Green 
Reagents chemistry.10-fold dilution series of the template were prepared for 
running the standard curve. 200 ng of each sample were used for the reaction 
and each reaction was run in triplicate to measure reproducibility. 10 µM of 
each primer were mixed with 25 µl SYBR Green Master Mix (Applied 
Biosystems) and the total reaction volume was 50 µl. The data analysis was 
done with the QuantStudioTM Design & Analysis Software. 
 
2.9 Breast cancer tissue analysis by Next Generation Sequencing 
2.9.1   DNA extraction from breast tissue samples 
Four DNA extraction methods were compared for the isolation of circular 
DNA molecules using approximately 25 mg of placenta tissue, to which known 
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amounts of plasmid vector (pUC19, 2700 bp and Nanoluc, 5900 bp) were 
added before starting the isolation procedure.    
a. Phenol-isoamyl-chloroform DNA extraction (isolation of total DNA) 
Approximately 25 mg placenta tissue were cut and placed into an 
Eppendorf tube containing 1.5 ml absolute ethanol. The sample was mixed 
by overnight rotation at room temperature. After a 5 min centrifugation at 
12000 rpm, the ethanol was removed and a defined amount of vector DNA 
was added to the pellet, which was subsequently lyophilized. Following, a 
standard phenol-isoamyl-chloroform DNA extraction was performed, 
followed by an ethanol precipitation (see.2.7.1). The DNA pellet was 
dissolved in an appropriate volume of TE buffer.  
b. DNeasy Blood & Tissue kit (QIAGEN) (isolation of total DNA) 
 
c. QIAprep® Spin Miniprep Kit (QIAGEN) (isolation of plasmid DNA) 
 
d. Plasmid Mini AX kit (A&A Biotechnology) (isolation of plasmid DNA) 
All three kits were used according to manufacturer’s protocol. For the plasmid 
kits, an additional step was added at the beginning of the DNA isolation. The 
mixture of placenta tissue and vector was rotated overnight at 37 oC with 250 
µl 2x PK Buffer and 10 µl Proteinase K dilution in a total volume of 500 µl. The 
final elution was performed in 50 µl elution buffer or TE buffer.     
2.9.2   Plasmid-SafeTM ATP-Dependent DNase digestion 
In order to enrich DNA samples obtained from different types of tissue for 
circular DNA molecules, the samples were treated with Plasmid-SafeTM ATP-
Dependent Dnase, an enzyme which selectively digests linear DNA 
molecules. Therefore, the DNA samples were subjected to RCA (see 2.7.3) 
followed by digestion with Plasmid-SafeTM ATP-Dependent DNase (Epicentre® 
Technologies). 2 µg DNA were digested according to manufacturer’s protocol 
(Table 2.7) for 30 min at 37 oC. The enzyme was inactivated at 70 oC for 30 
min and the DNA was subjected to ethanol precipitation (see 2.7.1) before 
being dissolved in an appropriate volume of TE buffer. 
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Table 2.7 Plasmid-Safe DNase digestion protocol. 
Component Amount 
DNA 2 µg 
25 mM Reaction Buffer 2 µl 
Plasmid-Safe DNase (10 U) 1 µl 
Sterile water x µl 
Total volume 50 µl 
 
 
2.9.3   Quality control before library generation 
The quality of the resulting DNA samples was assessed before library 
generation using the Agilent DNA 12000 Kit (Agilent Technologies) according 
to the manufacturer’s protocol on a Agilent 2100 Bioanalyzer (Agilent 
Technologies).  
 
2.9.4   Library preparation & sequencing 
The libraries for NGS of DNA were prepared using the TruSeq Nano (Illumina) 
protocol for formalin-fixed paraffin-embedded (FFPE) samples according to 
the manufacturer’s instructions. All libraries were barcoded in order to 
distinguish the different samples, pooled and sequenced in one lane. Both the 
generation of the libraries and the sequencing were performed by the 
Genomics Core Facility of the DKFZ.    
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 2.9.5   Bioinformatical analysis 
Table 2.8 Programs used for the bioinformatical analysis. 
Program / custom pipeline Version Application Reference 
(Ref or PMID 
or URL) 
EvalRSeq following 5 tools 
were used: 
1.2 Filtering and mapping  
Fastq_quality filter and 
artifacts filter from the 
FASTX Toolkit 
0.0.13 Quality, artifacts filtering http://hannonla
b.cshl.edu/fast
x_toolkit/index.
html 
Homertools 4.7 Removal of PolyA and reads 
< 17 bases 
20513432 
Cutadapt 1.71 Removal of Adapter 
sequences 
http://dx.doi.or
g/10.14806/ej.
17.1.200 
CollectRnaSeqMetrics from 
Picard tools 
1.78 Quality check of RNA-Seq 
data 
https://broadins
titute.github.io/
picard/ 
Tophat2 2.014 Mapping of reads to the 
human genome 38, splice 
aware 
23618408 
Other tools used:    
bedtools bam to fastq 2.17.0 Converts a BAM file into a 
FASTQ file 
20112078 
Bowtie2 2.1.0 Alignment of sequencing 
reads to long virus reference 
sequences (i.e. group 
isolates) 
22388286 
sam tools view 0.1.8 Converts a SAM file into a 
BAM file 
http://www.htsli
b.org/ 
sam tools sort 0.1.8 Creates a sorted copy of a 
BAM file 
http://www.htsli
b.org/ 
fq2fa from IDBA-UD 1.1.1 Converts fastq to fasta input 
in IDBA-UD 
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IDBA-UD 1.1.1 de novo Assembler 10.1093/bioinfo
rmatics/bts174 
get_circular_contigs.csh  Provides a fasta file with the 
sequences of probable 
circular contigs 
Jorgensen, Xu 
et al. 2014 
get_circularization_paired_r
eads.csh 
 Provides a fasta file with the 
sequences of probable 
circular contigs 
Jorgensen, Xu 
et al. 2014 
BLAST+ , megablast 2.2.18 Finds regions of similarity to 
databases or genomes 
20003500 
STAR 2.5.0 Maps short sequence reads to 
a whole genome focusing on 
the recognition of spliced 
transcripts 
23104886 
 
 
2.9.5.1   NGS data analysis 
The goal of the procedure followed for the analysis of the obtained data was 
the identification of circular DNA sequences of non-human origin from breast 
cancer tissue samples. Therefore, the procedure was designed according to 
this goal and it was the following: 
 Quality Filtering Phred score between 20 and 90 
 Removal of sequence of adapter at 3´ end AGATCGGAAGAG 
(cutadapt) 
 Removal of sequence of adapter at 5´ end AGATCGGAAGAG 
(cutadapt)  
 Trimming of Artifacts on 
 Sorting by Length > 17 
 Removal of all reads which contain “N”s 
 Reference genome for mapping and quality check: Human genome 38 
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 No removal of duplicates in final BAM file 
 Tophat2 as aligner for genomic mapping with default parameters, using 
the EvalRseq software. 
 
The unmapped reads were assembled de novo using IDBA-UD with the 
following parameters: 
 minimum contigs 100 
 number of threads 5 
 maximum kmer 80 
The tools used to discover circular contigs from reads (see Table 2.7) were 
adapted  from Jorgensen et al. (Jorgensen, Xu et al. 2014). The 
corresponding Pearl Scripts were implemented into two shell scripts: 
get_circular_contigs.csh, and get_circularization_paired_reads.csh (150 
bases at contigs ends). Those scripts were run using the assembled contigs 
from as input. The resulting fasta file contained the sequences of potential 
circular contigs. The resulting candidates for circular DNA sequences were 
then cleaned for sequences with more than 50% identity to human DNA by 
blasting them against the human genome hg38 using the MegaBlast (Blast+, 
NCBI, parameters -e 0.0001 -m 8 -v 3 -b 3 -D 3 -a 2). Small contigs < 200 
bases were removed. In order to detect circular DNAs with similarity to known 
viruses, finally, a MegaBlast search of the filtered contigs against the 
database of previously isolated virus genomes was performed. 
In a second approach, the mapping of the NGS reads to the human genome 
38 was performed using the STAR mapping algorithm (parameters --
outReadsUnmapped Fastx --outFilterMultimapNmax 100000 --
seedMultimapNmax 500000 --limitOutSJoneRead 100000 --
limitOutSAMoneReadBytes 6000000 --outSAMtype BAM Unsorted). The 
following de novo assembly was done as mentioned above. MegaBlast 
searches against the NCBI non-redundant database (October 2017, 
44,394,022 sequences; parameters -v 10 -b 10 -e 0.01) and the viral and 
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bacterial EMBL databases (September 2017; parameters -v 10 -b 10 -e 0.01) 
were conducted in order to detect similarities with the circular contig 
candidates. 
  
2.10 Cell Culture 
2.10.1   Cultivation of human cells 
Two human cell lines, the L-1236 and L-428, were used in this study. These 
suspension cells were cultured in suspension culture flasks (Greiner bio-one) 
in RPMI-1640 Medium, with L-Glutamine and sodium bicarbonate (Sigma 
Aldrich) containing 10% (v/v) fetal bovine serum (FCS) and 1% (v/v) 
Pen/Strep (Sigma Aldrich) at 37oC and 5% CO2. Cells were passaged 
regularly, maintaining them at a desity of about 0.5-1 x 106 cells/ml in order to 
keep them in an exponential growth phase. During passaging, cells were once 
washed with sterile 1x PBS.  
 
2.10.2   Mycoplasma test 
The cells were regularly tested for contamination with mycoplasma using the 
Venor®GeM Classic kit (Minerva Biolabs) according to manufacturer’s 
protocol for Taq polymerase 5 U /µl (AmpliTaq Gold DNA Polymerase with 
Gold Buffer and MgCl2, Applied Biosystems). The presence of mycoplasma-
indicating PCR products was assessed by agarose gel electrophoresis on a 
1.5% agarose gel (see 2.7.5).  
 
2.10.3   Cell counting 
Cell counting was performed with 20 µl cell solution in a Neubauer chamber 
using a 1:2 dilution of Trypan Blue (Thermo Scientific). The concentration was 
calculated based on the formula: 
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where 2 corrects for the 1 : 2 dilution of the Trypan Blue and the number of 
big squares is 4.  
In addition to the above mentioned manual cell counting, also an automated 
cell counting was used in this study. The corresponding CountessTM Cell 
Counting Chamber Slides (Invitrogen) and the Countess® Automated Cell 
Counter (Invitrogen) have been used according to the manufacturer’s 
instructions. 
 
2.10.4  Cultivation of new cells 
In order to avoid phenotypic changes of the used cell lines due to a high 
number of passages, fresh vials of the corresponding cell line were taken in 
culture before each experiment. Cell stocks stored in freezing medium in cryo 
tubes in liquid nitrogen were thawed rapidly and mixed with fresh RPMI-1640 
medium containing 10% FCS and 1% Pen/Strep, pre-heated to 37oC. Cells 
were then centrifuged at 300 x g for 10 min at room temperature. After 
washing of the cell pellet with sterile 1x PBS, cells were resuspended  in 
culture medium and transferred into a cultivation flask for further cultivation. 
 
2.10.5   Preparation of frozen cell stocks 
Once freshly cultivated cells reached 70-80% confluency, aliquots were stored 
in liquid nitrogen.  Therefore, the cells were centrifuged for 10 min in 300 x g 
at room temperature and the cell pellet was resuspended in freezing medium 
at a density of 1 x 106 cells per ml. The vials were stored for two days in a box 
at -80 oC to assure slow temperature decrease and finally transferred into 
liquid nitrogen. 
 
2.10.6   DNA transfection 
Both cell lines used in this study were transfected with the NucleofectorTM 2b 
Device (LONZA) using the Nucleofector® Kit V (LONZA) according to the 
             Materials & Methods 
 
50 
 
manufacturer’s protocol. Briefly, the required amount of cells (1 x 106 cells per 
sample) were centrifuged at 300 x g for 10 min at room temperature and the 
supernatant was completely discarded. The cell pellet was dissolved in 100 µl 
of Nucleofector® solution at room temperature containing the supplement and 
the desired amount of circular DNA (up to 2 µg) was added. The cell/DNA 
suspension was transferred into a certified cuvette, which was then placed 
into the NucleofectorTM 2b Device (LONZA) and the appropriate program for 
each cell line was applied (X-001 for the L-1236 cells and X-005 for the L-428 
cells). Once the program was finished, the cuvette was taken out of the holder 
and ~500 µl of pre-equillibrated cell culture medium (RPMI-1640 medium 
containing 10% FCS and 1% Pen/Strep) was added. The mixture was 
transferred gently into a T-25 cell culture flask containing 4 ml of pre-
equilibrated culture medium. Five nucleofection reactions were performed per 
condition, resulting in a final volume of 7 ml per T-25 cell culture flask. Due to 
the low proliferation of the L-1236 cells, for these cells two flasks per condition 
were transfected. A mock transfection using 1x TE buffer instead of DNA was 
used as a transfection negative control. The transfection efficiency was 
assessed by counting of green-fluorescent cells 24h and 48 h after the 
transfection of 2 µg of the pmaxGFP® Vector (LONZA). 
 
2.10.7   Cell harvesting 
Harvesting was performed at different time points after transfection. More 
specifically, total DNA, RNA and protein was harvested at days 3, 7, 10, 14, 
28, 35 and 42 post transfection. The cell culture supernatants were collected 
as well for each time point and stored at -80 oC. After centrifugation at 300 x g 
for 10 min at room temperature, the cell pellet was washed once with sterile 
1x PBS, before being dissolved in 5 ml fresh culture medium RPMI-1640 
medium containing 10% FCS and 1% Pen/Strep. 1 ml of this cell solution was 
used for harvesting and the remaining 2 ml were transferred back to the flask 
containing 5 ml of fresh culture medium for further cultivation.  
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Total DNA was extracted using the DNeasy Blood & Tissue kit (QIAGEN) 
according to the manufacturer’s protocol, while an additional washing step 
with 1x PBS was included at the beginning. The elution volume was 100 µl. 4 
μg if the extracted total DNA were digested with 100 U DpnI enzyme 
(Fermentas) in a total volume of 400 μl overnight at 37oC in order to remove 
transfected input DNA. The DpnI-resistant DNA was subsequently 
precipitated with ethanol (see 2.7.1) and 200 ng were used for replication 
analyses with PCR or qPCR reactions. 
The QIAshredder cell-lysate homogenizers (QIAGEN) were used according to 
the manufacturer’s protocol for lysate homogenization which was stored at -80 
oC for RNA isolation in the future. 
For protein extraction, cells were washed with 1 x PBS and subsequently 
dissolved in 2.5x Lämmli buffer. The mixture was then boiled at 95 oC for 5 
min, followed by 5 min centrifugation at 14000 x g  and stored at -20 oC for 
further analysis.  
 
2.10.8   Infection of fresh cells with supernatants collected during 
transfection  
Infection experiments of freshly clultured cells were performed using the 
supernatants collected at the harvesting time points of transfection 
experiments. Prior to infection, supernatants were centrifuged at 5000 x g for 
15 min at room temperature and the supernatant was filtered through 0.22 µm 
filters (Low protein Binding Durapore, Millipore Millex-GV) in order to remove 
remaining cells and cellular debris. Three days prior to infection 1.2 x 106 cells 
were treated with 50 µl 10 mM N-glycolylneuraminic acid (Neu5Gc, Sigma 
Aldrich) in a total volume of 5 ml cell culture medium (100 μM final 
concentration). A flask with water instead of Neu5Gc was included as a 
negative control of each condition. The infected cells were incubated for 2h at 
37 oC and 5% CO2. Then 3.6 ml of fresh medium RPMI-1640 medium 
containing 10% FCS and 1% Pen/Strep and 50 μl 10 mM Neu5Gc (Sigma 
Aldrich) or H2O were added and incubation at the above-mentioned conditions 
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was continued. Total DNA was harvested at days 3, 7, 10 and 14 post 
infection from 2 ml cell solution. During each passaging step, Neu5Gc was 
added at a final concentration of 100 μM.   
 
2.10.9   Phenotypic analysis 
2.10.9.1  Cell viability assay 
In order to assess cell viability, a cell viability assay was performed in a 96-
well-plate format using the CellTiter-Glo Luminescent Cell Viability Assay kit 
(Promega) using 50000 cells in a final volume of 100 µl in each well. The 
luminescent signal was measured after 24h, 48h and 72h according to the 
manufacturer’s protocol and cell viability was calculated according to it. 
 
2.10.9.2   Cell proliferation assay 
Cell proliferation was tested using the Click-iTTM Edu Plus Alexa FluorTM 647 
Imaging Kit (Thermo Scientific) as recommended by the manufacturer. Cell 
proliferation was measured after 24h, 48h and 72h following the 
manufacturer’s protocol. The cells were fixed by a drop wise addition of cold 
70% ethanol before being washed with 5% FCS in 1x PBS. The cells were 
analyzed by flow cytometry using 633 / 635 nm excitation with a red emission 
filter. 
 
2.11 Protein biochemical methods 
2.11.1    SDS PAGE 
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS PAGE) was 
used for separation of proteins according to their molecular weight. SDS is a 
detergent with a substantial protein-denaturing effect, that along with boiling 
and a reducing agent (such as β-mercaptoethanol), disrupts the tertiary 
structure of proteins unfolding them into linear chains with negative charge 
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proportional to the polypeptide chain length. Therefore, the proteins are 
separated solely by their size in the polyacrylamide gel in an applied electrical 
field. For protein separation the commercially available TruPAGETM Precast 
Gels 4-20% (Sigma Aldrich) were used. The protein solutions were pre-
heated at 95 oC and 15 µl were loaded on the gel. 5 µl Page RulerTM 
Prestained Protein Ladder (Fermentas) (Fig. 2.2) were loaded, as well as 5 µl 
positive control (MSBI1.176 codon optimized Rep protein). Gels were run at 
100 mA in 1x TruPAGE SDS running buffer (Sigma Aldrich). 
 
 
Figure 2.2 Page RulerTM Prestained Protein Ladder (Fermentas).  
 
2.11.2    Immunoblotting 
The separated proteins were transferred to a nitrocellulose membrane using 
the Trans-Blot® TurboTM Transfer System (Bio-Rad) according to the 
manufacturer’s instructions using the MIXED MW protocol.  
 
2.11.3    Ponceau S staining 
Ponceau S was used for rapid detection of microgram quantities of proteins 
transferred to a nitrocellulose membrane. Ponceau S staining is a reversible 
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technique that allows further immunological detection. For staining, the 
membrane was incubated on a shaker in a sufficient amount of Ponceau S 
staining solution. Afterwards, it was washed two times with water and the 
protein-less background was defined. The membrane was completely 
destained by washing with water containing 8 mM NaOH for 10 min. A 
additional washing step with water was performed in order to remove 
remaining NaOH that would interfere with the downstream processes.  
 
2.11.4    Immunodetection 
Immunological detection was used to identify specific proteins after blotting. 
This is a chemiluminescence-based method, using a horseradish peroxidase 
(HRP)-conjugated secondary antibody and an enzymatically activated 
substrate for the detection of the primary antibody which is specific for the 
protein of interest. Following transfer, blocking is an important step that 
prevents antibodies from binding to the membrane non-specifically. The 
membrane was incubated in blocking buffer for 1 h on a shaker at room 
temperature followed by addition of the primary antibody (1:5000 dilution) and 
an overnight incubation at 4 oC. The blot was washed four times for 10 min in 
washing buffer before the secondary antibody was applied in 5% skim milk / 
PBS buffer at a dilution of 1:5000 for 1h on a shaker at room temperature. 
Finally, four washing steps in washing buffer, for 10 min each, were 
performed. Then, the blot was developed using the ClarityTM Western ECL 
Substrate (Bio-Rad) in a 1:1 mixture of peroxide and lumino/enhancer 
solution. Development was performed in a blot imager. The membranes were 
either stored or treated with additional antibodies. 
 
 
2.11.5    Stripping of membranes 
In certain cases, one membrane was probed with two different primary 
antibodies. Therefore, the previous primary antibody had to be efficiently 
removed by stripping. Therefore,  the membrane wasincubated for 15 min at 
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37 oC in RestoreTM PLUS Western Blot Stripping Buffer (Thermo Scientific) 
followed by two washing steps with washing buffer , before incubation with the 
new primary antibody of interest. 
 
2.12 ELISA experiments & serology 
Serum samples from breast cancer and Hodgkin’s Disease patients were 
analyzed for human anti-MSBI1.176 Rep antibodies using ELISAs.  
 
2.12.1   ELISA protocol 
200 ng per well of antigen were diluted in PBS 4M Urea and 100 µl of diluted 
antibody were pipetted in each well of microtiter plate (MaxiSorp, Thermo 
Scientific). Each sample was in triplicates. The plate was covered with 
adhesive plastic and incubated at 4oC overnight. The coating solution was 
removed and the plate was washed with 150 µl PBS. Blocking was done with 
100 µl Superblock® T20 (PBS) Buffer (Thermo Scientific) and incubation for 2 
h at room temperature on a shaker. Subsequently a 1:500 dilution of serum 
samples was prepared in Superblock and 100 μl were added in each well and 
incubated for 2 h in 37oC. The blocking solution was then removed and the 
plate was washed three times with 150 µl PBS 0.1% Tween 20, with the first 
washing to be directly removed, while for the two remaining a 10 min 
incubation was included. Washing was followed by 1 h incubation of a HRP-
coupled goat anti-human secondary antibody (100 μl in each well) in a dilution 
of 1:5000 in Superblock on a shaker in room temperature. The plate was 
subsequently washed 3x with 150 µl PBS 0.1% Tween 20. The color 
development was done by adding 100 μl TMB Substrate Solution (Thermo 
Scientific) and stopped by adding 100 μl stop solution. Absorbance was 
recorded at 450 nm.  
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3.  Results 
 
 
3.1 Isolation and identification of episomal DNA agents from cow milk 
and dairy products 
 
A number of circular episomal DNA agents has been isolated by our 
group from commercially available cow milk and healthy bovine cattle, named 
bovine milk and meat factors (BMMFs), as well as from blood and tissue 
samples from MS patients (Funk, Gunst et al. 2014, Gunst, Zur Hausen et al. 
2014, Lamberto, Gunst et al. 2014, Whitley, Gunst et al. 2014). Part of this 
thesis was to continue this work and to expand it to different types of dairy 
products. Therefore, DNA was isolated by phenol-isoamyl-chloroform 
extraction from commercially available cow milk, yogurt, card cheese, crème 
fraiche and butter (see Appendix for a full list of the products). Subsequently, 
the DNA preparations were subjected to Rolling Circle Amplification (RCA) 
using random primers, in order to specifically amplify small circular DNA 
molecules. Specific primers (see 2.3) for the BMMF1 group were used in 
order to identify such agents related to the already identified DNA agents (zur 
Hausen, Bund et al. 2017) by conventional PCR (Figure 3.1). The obtained 
DNA molecules were subsequently cloned and sequenced. 
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Figure 3.1 Long-PCR with specific primers on DNA isolated from 
commercially available yogurt and milk samples after RCA. A) Bands 
obtained with the NnXn primers and B) bands obtained with the NoXo 
primers. The obtained molecules were cloned and sequenced. 
 
 
By this approach, two novel circular DNA sequences were isolated from 
the same milk sample (mi7, more information in Appendix), CMI5.170 (1706 
bp) and CMI5.240 (2406 bp) (Falida, Eilebrecht et al. 2017) (Figure 3.2).  
 
 
                
 
Figure 3.2 Circular representation of the newly isolated agents CMI5.170 and 
CMI5.240. The Rep protein is represented in pink, the additional open reading 
frame of the CMI5.240 is indicated in blue and the green line indicates the 
conserved repeat region upstream of the Rep open reading frame. 
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CMI5.170 shares 89% nucleotide identity to the previously identified MS 
brain isolate MSBI1.170 (1766 bp), while for CMI5.240 the nucleotide identity 
to MSBI1.176 is 68%. Figure 3.3 summarizes the similarities among the 
isolates of the BMMF1 group including the newly isolated genomes CMI5.170 
and CMI5.240.     
 
Figure 3.3 ClustAL W dendogram showing the similarity of the BMMF1 group 
and the newly isolated CMI5.170 and CMI5.240.  
  
  
The open reading frame (ORF) encoding a putative replication 
associated protein is highly conserved among all BMMF1 isolates. The 
encoded putative Rep proteins show identities of 50-98% of amino acids. 
CMI5.240 contains an additional ORF of 125 aa in the antisense direction and 
it is 96% identical at amino acid level to an antisense-directed ORF found in 
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CMI2.214 (Whitley, Gunst et al. 2014). Both isolates contain a highly 
conserved A/T-rich region, which is followed by a repeat region upstream of 
the Rep ORF as it has been previously reported for the other isolates (zur 
Hausen, Bund et al. 2017) (Figure 3.4).  
Apart from these new isolates, three of the previously isolated agents 
were also isolated from additional dairy products. CMI3.168 was isolated from 
milk, yogurt and curd cheese, CMI4.158 from milk and HCBI6.252 from milk 
and yogurt (Falida, Eilebrecht et al. 2017).  
 
 
 
Figure 3.4 CLUSTAL alignment of the repeat region of the BMMF1 group and 
the newly isolated CMI5.170 and CMI5.240.  
 
Specific back-to-back primer sets located within the conserved region of 
BMMF2 group of isolates (Sphinx2.36-related) have been used for long-PCR 
reactions using DNA samples isolated from the above mentioned dairy 
products and additional milk samples as a template, revealing a number of 
additional, novel isolates (15-30 new isolates) and indicating that there is a 
significant multitude of such circular episomal agents that might have a 
potential role in human diseases. 
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3.2 Identification of episomal DNA agents in breast cancer biopsies by 
Next Generation Sequencing (NGS).  
 
In addition to the classical molecular biology-based DNA isolation 
techniques shown before, also isolation of DNA from breast cancer tissue 
samples by NGS was performed. Milk and dairy product consumption has 
been previously linked to breast cancer (zur Hausen and de Villiers 2015). 
Assuming a role of BMMF infection during breast cancer formation, the 
corresponding BMMF genomes should be identifiable by NGS of total DNA 
isolated from breast cancer tissue, since a transfer of BMMFs to their target 
cells is assumed after initial infection early in life. For the identification of novel 
agents, a high throughout NGS approach has been chosen, since it 
represents a powerful tool and the obtained data can be subjects to 
metagenome based analysis for the discovery of novel human viruses 
(Barzon, Lavezzo et al. 2011). This requires special sample preparation and 
enrichment in order to detect very low abundance of virus populations over 
the cellular DNA background.  
Therefore a protocol was established specifically for the isolation of 
circular DNA molecules by comparing four different DNA extraction methods 
(see 2.8.1). In order to test the efficacy of each method, known amounts of 
plasmid vector (pUC19, 2700 bp) were added to approximately the same 
amount of placenta tissue (25 mg) before DNA isolation. This spiked tissue 
was then used as testing material. Four different vector amounts were used, 
representing approximately 10 pg, 2 pg, 200 fg and 100 fg. 
After DNA extraction with the four methods, long-PCR was performed 
using specific primers for pUC19 (Figure 3.5).  
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Figure 3.5 Long-PCR on DNA extracted from placenta tissue with indicated 
amounts of pUC19 plasmid using pUC19-specific primers and comparing 
different sample preparation techniques. The band intensity reduces as the 
amount of pUC19 reduces for the plasmid kits, while it remains stable for the 
DNeasy kit. The observed difference between the conditions of 200 fg and 
100 fg of pUC19 in the phenol/chloroform extraction was due to technical 
problems in the long-PCR. 
 
The samples with the lowest amount of pUC19 DNA (3 molecules of 
pUC19 / 100 cells) were used for further processing. Additionally, a larger 
plasmid was used in a parallel approach (Nanoluc vector, 5900 bp) in order to 
test for differences on the enrichment between small and large DNA 
molecules (see below).  
RCA was used for a specific enrichment of circular DNA molecules. In 
addition, the effectivity of a Plasmid-Safe DNase treatment was tested, which 
selectively digests contaminating linear genomic DNA molecules from plasmid 
DNA preparations. The enrichment of the plasmid DNA after RCA as well as 
the effectiveness of the Plasmid-Safe DNase digestion were tested by RT-
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qPCR analyses for both plasmids (pUC19, Figure 3.6 and Nanoluc, Figure 
3.7). A significant enrichment of the plasmid DNAs after RCA was observed in 
all extraction methods. Notably, an increase of up to 350 fold was observed 
after Plasmid-Safe DNase digestion.  
 
 
 
Figure 3.6 RT-qPCR data representing the enrichment of pUC19 plasmid 
DNA in each extraction method before and after RCA as well as after RCA 
upon Plasmid-Safe DNase digestion. A region within the beta actin gene was 
amplified in parallel for each sample using specific primers, in order to control 
for the amount of input DNA. 
 
 
 
Figure 3.7 RT-qPCR data representing the enrichment of Nanoluc plasmid 
DNA in each extraction method before and after RCA as well as after RCA 
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upon Plasmid-Safe DNase digestion. A region within the beta actin gene was 
amplified in parallel for each sample using specific primers, in order to control 
for the amount of input DNA. 
 
The DNA isolation with the DNeasy kit (QIAGEN) showed the strongest 
enrichment for larger plasmids such as the Nanoluc vector. DNA extraction 
using the Plasmid Mini AX kit (A&A Biotechnology) most efficiently enriched 
smaller plasmids such as the pUC19 vector. Therefore, these two kits were 
chosen for isolation of DNA from the breast tissue samples.  
Eleven breast tumor tissue samples and their respective tissue adjacent 
to tumor (TAT) control tissues of the same patients were used for DNA 
extraction. DNA yields in tumor tissue were significantly higher than in normal 
tissues, as normal breast control tissue is predominantly fatty tissue 
containing significantly less cells than tumor tissue. As it was not possible to 
obtain sufficient amounts of DNA for further processing using the Plasmid Mini 
AX kit (A&A Biotechnology), all further analyses were performed with the total 
DNA obtained with the DNeasy kit (QIAGEN). The isolated DNA was 
subsequently subjected to Plasmid-Safe DNase digestion followed by RCA 
with random primers and ethanol precipitation. 
One patient sample (tumor and control) was used for a NGS pilot 
experiment. In this pilot experiment, the vast majority of potentially circular 
contigs were identified as human sequences, necessitating a more efficient 
removal of human reads before contig generation. Moreover, the samples 
were initially amplified by RCA and thus differ substantially from typical 
genomic DNA samples, which may have negatively impaired sequencing 
depth. For example, the DNA fragments used for library generation were 
larger than the optimal ones resulting in a significantly reduced number of 
reads. Therefore, the library preparation method was changed to a protocol 
for formalin-fixed paraffin-embedded (FFPE) samples for the remaining 
samples.  
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This protocol for library generation was successfully performed for DNA 
from seven tumor and their corresponding TAT samples. The sequencing was 
performed using a HiSeq4000 Illumina platform generating paired-ends of 100 
bp. The samples were pooled in one lane using different barcodes in order to 
be able to distinguish the different samples during data analysis and each 
sample had an adequate number of reads obtained after sequencing (Table 
S3, in Appendix).  
After generation of potentially circular contigs, these were analyzed for 
similarities to the previously identified BMMFs. One circular contig of 1620 bp 
size was identified in a TAT sample (7717N), which showed 85% similarity to 
the previously isolated MSSI.162 (Gunst, Zur Hausen et al. 2014) according 
to BLAST search (Figure 3.8, 7717N_contig_80). The significant differences 
between the two genomes at the nucleotide level exclude the possibility of a 
laboratory contamination. This contig showed also 95% similarity to an 
uncultured bacterium plasmid clone HD10Abpcirc putative replication protein 
gene isolated from plasma of patients in maintenance hemodialysis deposited 
in the GenBank under the accession number KX838914 (Biagini,P.).  
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Figure 3.8 A) Circular representation of the contig found in breast TAT tissue 
sample. B) Alignment of the circular contig with the previously isolated 
MSSI1.162 and the plasmid gene isolated from Biagini (KX838914). 
 
 Back-to-back primers were designed based on the 7717N_contig_80 
sequence and PCR reactions using these primers were performed in all 
fourteen initial RCA samples used in this study. Solely the 7717N sample 
showed a positive signal at the expected height, proving the physical 
presence of the corresponding circular DNA molecule (Figure 3.9)  
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One of the samples (7728T) was excluded from further analysis due to 
contamination with circular MSBI1.176 genome cloned to pUC19 vector as 
revealed from the analysis. Although this was clearly a contamination, it was 
at the same time a confirmation of the success of the analytical process that 
was used.  
 
 
Figure 3.9 PCR with specific back-to-back primers on the seven breast tumor 
tissue samples (7714T-77124T) and the corresponding TAT controls (7714N-
7724N) confirming the presence of the new isolate only in the expected 
(7717N) sample with approximately 1600 bp size.  
 
In a parallel effort, restriction digestion analyses using various 
restriction enzymes and PCR analyses using specific back-to-back primers for 
the previously identified agents were performed on the initial RCA samples. 
However, none of these approaches resulted in the identification of novel 
episomal DNA agents. All resulting DNA fragments cut and cloned 
corresponded to human DNA sequences. 
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3.3 Replication of Cattle-Derived Milk and Meat factors (BMMF) in 
human cells and analysis of their involvement in human breast 
cancer and in Hodgkin´s Lymphomas.  
 
This project focused on the search for a permissive cell system for the 
identified BMMFs. Several epidemiological studies point to a link between the 
consumption of milk and red meat and general animal exposure and the 
development of Hodgkin’s disease (Khuder, Mutgi et al. 1999, Epstein, Chang 
et al. 2015). In addition, 24 full-length TT Viruses (a single-stranded DNA 
virus) have been isolated from a single spleen biopsy sample from a patient 
with Hodgkin’s lymphoma (Jelcic, Hotz-Wagenblatt et al. 2004). In order to 
test replication competence of BMMFs in cells derived from Hodgkin’s 
disease, two Hodgkin’s Lymphoma cell lines, the L-1236 and L-428 cell lines, 
were selected for transfection with the Multiple Sclerosis brain isolate 
MSBI1.176, which was recently shown to have the highest transcriptional 
activity and protein expression in human HEK293TT cells (Eilebrecht, Hotz-
Wagenblatt et al. 2018). The L-1236 and the L-428 cells are pre-B cells 
(Kuppers, Rajewsky et al. 1994). Blood cells of the B cell lineage may 
probably transport BMMFs to the affected organ (in this case lymphoid 
tissue). Notably, previous experiments (zur Hausen, unpublished data) 
showed small putative particles in the L-1236 cells after infection with herpes 
simplex virus (HSV-1), which may hint at viral infections playing a role in the 
pathogenesis of Hodgkin’s disease.  
 
 
3.3.1 Transfection with MSBI1.176  
To analyze replication of BMMFs in the above mentioned cell lines, 5-
10×106 cells were transfected with circularized MSBI1.176 genome and a 
mock condition with addition of TE buffer instead of DNA was included as a 
negative control. Total DNA and protein were collected at days 3, 7, 10, 14, 
28 and 36 post transfection and supernatants were collected and frozen at -
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80oC (see 2.9.6 and 2.9.7). DNA was digested with DpnI restriction enzyme in 
order to remove methylated input DNA while retaining non-methylated 
replicated DNA. Subsequently, PCR reactions were performed with the DpnI–
digested samples as a template using specific primers for the detection of 
MSBI1.176 (Figures 3.10A, 3.11A).  
 
Figure 3.10 A) PCR after DpnI digestion on DNA extracted from L-1236 cells 
after transfection with MSBI1.176 using MSBI1.176-specific back-to-back 
primers. Circular MSBI1.176 was used as a template for a positive control 
reaction and DpnI-digested circular MSBI1.176 was used as a template for a 
negative control reaction. B) qPCR data representing the number of 
MSBI1.176 molecules per cell at different harvesting time points of L-1236 
cells. A region within the beta actin gene was amplified in parallel for each 
sample using specific primers, in order to control for the amount of input DNA. 
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C) qPCR data representing the ratio of MSBI1.176 DpnI digested DNA to 
MSBI1.176 non-DpnI digested DNA at different harvesting time points of L-
1236 cells. A region within the beta actin gene was amplified in parallel for 
each sample using specific primers, in order to control for the amount of input 
DNA. 
 
 
 
Figure 3.11 A) PCR after DpnI digestion on DNA extracted from L-428 cells 
after transfection with MSBI1.176 using MSBI1.176-specific back-to-back 
primers. Circular MSBI1.176 was used as a template for a positive control 
reaction and DpnI-digested circular MSBI1.176 was used as a template for a 
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negative control reaction. B) RT-qPCR data representing the number of 
MSBI1.176 molecules per cell at different harvesting time points of L-428 
cells. A region within the beta actin gene was amplified in parallel for each 
sample using specific primers, in order to control for the amount of input DNA. 
C) RT-qPCR data representing the ratio of MSBI1.176 DpnI digested DNA to 
MSBI1.176 non-DpnI digested DNA at different harvesting time points of L-
428 cells. A region within the beta actin gene was amplified in parallel for 
each sample using specific primers, in order to control for the amount of input 
DNA. 
 
MSBI1.176 was detected up to day 36 post-transfection in both cell lines 
using the DpnI-digested DNA samples as a template for PCR reactions, 
pointing at synthesis of new, non-methylated DNA molecules during 
productive replication of MSBI1.176. While the band intensity declines 
towards later time points in L-1236 cells, it remains relatively stable until day 
36 post transfection in both cell lines.  
Quantitative-PCR (qPCR) confirms the above mentioned results 
obtained by PCR. Although the number of MSBI1.176 molecules decreased, it 
was still possible to detect approximately 1 molecule of MSBI1.176 per cell 
after 36 days post transfection in L-428 cells (Figure 3.11B) and 1 molecule 
per 5 cells in L-1236 cells (Figure 3.10B). The ratio of newly synthesized 
DNA molecules (DpnI-resistent) to input DNA (DpnI-sensitive) supports a 
productive replication (Figures 3.10C, 3.11C). 
Western Blot analyses using the protein samples extracted at different 
time points after transfection with MSBI1.176 using antibodies specific for the 
detection of MSBI1.176 Rep protein did not reveal a signal at the expected 
protein size (38 kDa) most likely0 due to the low general translation activity of 
BMMF1 genomes which was characterized in a recent study (Eilebrecht, 
Hotz-Wagenblatt et al. 2018) (see Figure in Appendix D). 
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3.3.2    Co-transfection experiments 
In previous studies it has been demonstrated that MSBI1.176 replicates 
abortively in HEK293TT cells (Eilebrecht, Hotz-Wagenblatt et al. 2018). 
However, co-transfection with CMI1.252 resulted in an increase of MSBI1.176 
replication. This detected helper effect aligns with similar phenomena 
observed in several viruses (Buller, Janik et al. 1981, Rosario, Duffy et al. 
2012). Based on these data, co-transfection experiments were performed in 
the L-428 cell line with different genomes in order to test a helper or 
interfering effect on the stable replication of MSBI1.176. 
 
3.3.2.1 Co-transfection of L-428 cells with MSBI1.176 and CMI1.252 
After co-transfection of L-428 cells with MSBI1.176 and CMI1.176, no 
effect was observed on the replication of MSBI1.252 after qPCR analysis. As 
MSBI1.176, CMI1.252 can replicate up to day 28 in this cell line when 
individually transfected, as well (Figure 3.12). 
 
 
Figure 3.12 RT-qPCR data representing the number of CMI1.252 molecules 
per cell at different harvesting time points of L-1236 cells. A region within the 
beta actin gene was amplified in parallel for each sample using specific 
primers, in order to control for the amount of input DNA.  
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3.3.2.2 Co-transfection of L-428 cells with MSBI1.176 and sg613 
There was a reproducible observation of extra-bands appearing at 
different sizes after transfection with MSBI1.176 in replication experiments. 
Due to its reproductive detection, a band of approximately 600 bp in the L-428 
cell line transfections (Figure 3.11A) appeared to be of special interest. This 
genome (named small genome 613, sg613) consisting of the MSBI1.176 
region covering the fourth repeat of the repeat region up to approximately     
of the Rep ORF (analyzed by E.M. de Villiers) was used to transfect the 
corresponding cell line. The results obtained from long-PCR with specific 
primers for the detection of the small genome showed that sg613 can 
replicate independently in this cell line (Figure 3.13).  
 
 
Figure 3.13 PCR after DpnI digestion on DNA extracted from L-428 cells after 
transfection with sg613 using sg613-specific back-to-back primers. Circular 
MSBI1.176 and sg613 were used as template for a positive control reaction 
and DpnI-digested circular MSBI1.176 and sg613 were used as template for a 
negative control reaction. 
 
                                  Results 
 
73 
 
Subsequently, this small genome was used for co-transfection 
experiments with MSBI1.176 in order to explore a possible helper or 
regulatory effect on the replication of MSBI1.176. However, no modulatory 
effect was detected on MSBI1.176 replication, which was checked by specific 
MSBI1.176 detection primers with long-PCR as well as with qPCR (Figure 
3.14). The amount of newly synthesized DNA molecules to input DNA 
confirmed that there is no significant effect on the replication of MSBI1.176, 
although a slightly elevated amount of MSBI1.176 molecules was detected in 
the single condition compared to the co-transfection. 
 
 
 
Figure 3.14 A) PCR after DpnI digestion on DNA extracted from L-428 cells 
after transfection with MSBI1.176 and co-transfection with MSBI1.176 and 
sg613 using MSBI1.176-specific back-to-back primers. Circular MSBI1.176 
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and sg613 were used as template for a positive control reaction and DpnI-
digested circular MSBI1.176 and sg613 were used as template for a negative 
control reaction. B) RT-qPCR data representing the number of MSBI1.176 
molecules per cell at different harvesting time points of L-428 cells for the 
single MSBI1.176 condition and the co-transfection with sg613. A region 
within the beta actin gene was amplified in parallel for each sample using 
specific primers, in order to control for the amount of input DNA. C) RT-qPCR 
data representing the ratio of MSBI1.176 DpnI digested DNA to MSBI1.176 
non-DpnI digested DNA at different harvesting time points of L-428 cells for 
the single condition of MSBI1.176 and the co-transfection with sg613. A 
region within the beta actin gene was amplified in parallel for each sample 
using specific primers, in order to control for the amount of input DNA. 
 
3.3.3 Transfection with MSBI1.176 and external addition of Neu5Gc 
It has been recently reported that the incorporation of N-
Glycolylneuraminic acid (Neu5Gc) into human cells leads to chronic 
inflammation which potentially promotes cancer and other diseases (Alisson-
Silva, Kawanishi et al. 2016). Neu5Gc cannot be synthesized in humans due 
to an exon deletion mutation in the enzyme responsible for the conversion of 
Neu5Gc from its precursor N-acetylneuraminic acid (Neu5Ac). In humans, 
Neu5Gc is metabolically incorporated via dietary consumption especially of 
red meat and cow milk. A number of reasons have been recently summarized 
supporting the idea that a functional receptor for BMMFs is established by 
Neu5Gc modification (zur Hausen, Bund et al. 2017).     
In order to test an involvement of Neu5Gc in the permissiveness of 
human cells for BMMF replication, a condition of MSBI1.176 transfection with 
external addition of 100 µM of Neu5Gc after day 3 post transfection and at 
every harvesting time point of the L-1236 cell line was included. However, no 
significant difference was detected after long PCR and qPCR, although the 
signal is slightly elevated for the condition with the external Neu5Gc during 
the first time points (Figure 3.15). 
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Figure 3.15 A) PCR after DpnI digestion on DNA extracted from L-1236 cells 
after transfection with MSBI1.176 and MSBI1.176 with external addition of 
100 μM Neu5Gc using MSBI1.176-specific back-to-back primers. Circular 
MSBI1.176 was used as a template for a positive control reaction and DpnI-
digested circular MSBI1.176 was used as a template for a negative control 
reaction. B) qPCR data representing the number of MSBI1.176 molecules per 
cell at different harvesting time points of L-1236 cells with and without addition 
of external Neu5Gc. A region within the beta actin gene was amplified in 
parallel for each sample using specific primers, in order to control for the 
amount of input DNA. 
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3.3.4    Infection experiments 
As mentioned earlier, Neu5Gc may be involved in the permissiveness 
of human cells for BMMF infection, In order to establish a general infection 
system for BMMFs and - in parallel - to test an involvement of Neu5Gc, 
infection assays were performed using MSBI1.176 positive supernatants of 
MSBI1.176-transfected cells (Figure 3.16). 
 
 
Figure 3.16 PCR analysis of DNA extracted from supernatants collected after 
transfection of L-1236 cells with MSBI1.176 and MSBI1.176 pre-treated with 
Neu5Gc after day 3 post transfection and at each harvesting time point using 
MSBI1.176-specific back-to-back primers. Circular MSBI1.176 was used as a 
template for a positive control reaction. Transfection with pUC19 vector and 
1xTE buffer were used as negative control reactions. 
 
Supernatants from cells at day 7 after transfection with i) MSBI1.176, ii) 
MSBI1.176 upon treatment of cells with Neu5Gc on day 3 after transfection, 
iii) pUC19 and iv) mock transfection with 1xTE buffer, were used for infection 
of the L-1236 cell line. Two cell culture conditions were tested, one in the 
presence of an approximately 100-fold excess of Neu5Gc and one without 
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addition of external Neu5Gc. Total DNA was harvested at different time points 
post infection and subsequently analyzed for the presence of MSBI1.176 by 
PCR using specific back-to-back primers, but no DNA uptake was observed 
for the target cells (Figure 3.17). The same applies for corresponding 
experiments performed in the L-428 cells (data not shown). However, 
infectivity of BMMFs remains elusive and technical improvements need to be 
done in order to further analyze a potential infectious system for BMMFs and 
prove an activation of the putative cellular receptors by a Neu5Gc 
modification.  
 
Figure 3.17 PCR on DNA extracted from L-1236 cells after infection with 
supernatants from transfection with MSBI1.176 and controls using 
MSBI1.176-specific back-to-back primers. Circular MSBI1.176 was used as a 
template for a positive control reaction. The red color letters indicate the 
                                  Results 
 
78 
 
conditions with 100-fold excess of Neu5Gc and the green color the ones 
without addition of external Neu5Gc. 
 
3.3.5    Cell viability and cell proliferation assay 
In order to assess BMMF effects on cell viability and proliferation, cell 
viability and proliferation assays were performed after transfection of L-428 
cells with linear MSBI1.176, circular MSBI1.176, an overexpression (OE) 
plasmid encoding for MSBI1.176 Rep wild type (WT) protein or a MSBI1.176 
Rep aggregation mutant protein (MUT).  
Cell viability was measured with the CellTiter-Glo® Luminescent Cell 
Viability Assay kit (Promega) (Figure 3.18). However, no significant impact on 
cell viability was observed when comparing each condition with the 
corresponding control reactions. 
 
 
Figure 3.18 Luminescent signal after transfection of L-428 cells with 
pcDNA3.1(-) control vector, MSBI1.176 Rep WT OE, MSBI1.176 Rep MUT 
OE, MSBI1.176 linear and MSBI1.176 circular genome measured at three 
different time points post transfection.  
 
 Cell proliferation was tested using the Click-iTTM Edu Plus Alexa 
FluorTM 647 Imaging Kit (Thermo Scientific) (Figure 3.19). No significant 
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difference in cell proliferation was observed when comparing cells 
overexpressing either wild type MSBI1.176 Rep protein or mutant MSBI1.176 
Rep protein with the corresponding controls at the different time points. 
 
Figure 3.19 Summary of cell proliferation assay in L-428 cells after 
transfection with pcDNA3.1(-) control vector, MSBI1.176 Rep WT OE protein 
and MSBI1.176 Rep Mut protein. A) representative EdU positive cells at 48h 
post transfection, B) percentage of EdU positive cells after 24h, 48h and 72h 
for all three conditions, C) western blot analysis suing anti-His Rep antibody 
and alpha tubulin as loading control. No difference was observed for the two 
genomes.   
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3.4 Serological tests  
 
A link of BMMFs to breast cancer or to Hodgkin’s disease etiology could 
lead to a detectable immune response to those agents specifically in patients 
suffering from the respective disease. In this case elevated antibody titers 
directed against BMMF gene products in sera of disease patients would be 
expected compared to healthy controls. 
To test the presence of serum antibodies (IgG in this study) in breast 
cancer patients, sera from breast cancer as well as Hodgkin’s Lymphoma 
patients were analyzed by ELISA assays in order to identify a potential 
immune reaction of those patients against the Rep protein of the MSBI1.176 
isolate (which is also highly conserved in the majority of the remaining 
identified agents of BMMF group1). The wild type MSBI1.176 rep protein was 
used as antigen and EBNA1 protein of Epstein Barr Virus (EBV) as a positive 
control and co-marker. A specificity of anti-Rep reactivity in human plasma 
samples has already been previously reported (Eilebrecht, Hotz-Wagenblatt 
et al. 2018). 
Out of 50 samples from patients suffering from Hodgkin’s lymphoma, no 
significant difference in seropositivity was observed as compared to plasma 
samples from healthy controls. Interestingly, for the 30 samples from breast 
cancer patients that have been analyzed significant difference was detected 
when compared to healthy plasma samples (Figure 3.20). The same samples 
were tested for EBNA1 response, but no significant difference was observed 
between the seropositivity of the disease samples in comparison to the 
plasma controls (Figure 3.21). 
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Figure 3.20 Box plot analysis based on ELISA results. Comparison between 
50 Hodgkin’s Lymphoma serum samples, 30 breast cancer serum samples 
and 30 plasma controls using Wild type (WT) Rep MSBI1.176 protein as 
antigen. 
 
 
Figure 3.21 Box plot analysis based on ELISA results. Comparison between 
50 Hodgkin’s Lymphoma serum samples, 30 breast cancer serum samples 
and 30 plasma controls using the EBNA1 protein as antigen.  
                                  Results 
 
82 
 
Additionally, plasma samples from female donors were compared with 
plasma samples from male ones, testing for gender- and age-based 
differences in antibody response. The corresponding data reveal no 
significant difference between the two genders (Figure 3.22).  Also for the 
age, no significant correlation was observed with the strength of the antibody 
response. 
  
 
Figure 3.22 Box plot analysis based on ELISA results. Comparison between 
plasma controls from female and male donors using the Wild type (WT) Rep 
MSBI1.176 protein as antigen. 
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4. Discussion 
 
Breast cancer is the most common cause of cancer mortality in women 
worldwide (Akram, Iqbal et al. 2017). Several factors are correlated with an 
increased risk of the disease (so called “risk factors”) including sex, age, 
family history and genetics, reproductive and menstrual history, endogenous 
and exogenous hormones, as well as personal and lifestyle factors, such as 
body size and weight, diet and nutrition (National Breast and Ovarian Cancer 
Center 2009). According to diet as risk factor, more specifically, a number of 
epidemiological studies indicate a potential relation between the consumption 
of red meat and milk and an increased incidence of breast cancer (Boyd, 
Stone et al. 2003, Moorman and Terry 2004, Taylor, Burley et al. 2007, Linos, 
Willett et al. 2008, Farlow, Xu et al. 2009, Kabat, Cross et al. 2009, 
Maruyama, Oshima et al. 2010, Farvid, Cho et al. 2015). In addition, it has 
been previously reported that species-specific risk factors might contribute to 
the development of breast cancer as well as colon cancer and 
neurodegenerative diseases like Parkinson’s disease and Multiple Sclerosis 
(zur Hausen and de Villiers 2015, zur Hausen, Bund et al. 2017). Looking 
closely into the dietary habits globally, as analyzed in these reviews, it is 
intriguing that dairy cattle is most prevailing in almost all high risk regions for 
development of breast and colon cancer, such as North America, most of the 
European countries and Australia, while in low risk countries, such as 
Mongolia and Bolivia, different cattle species are found (e.g. Yak or Zebu) (zur 
Hausen and de Villiers 2015). On the other hand, several studies suggest that 
viruses might play a role in the development of breast cancer, amongst them 
Human Papilloma Viruses (HPV), Epstein-Barr Virus (EBV), Mouse Mammary 
Tumor Virus (MMTV) and Bovine Leukemia Virus (BLV) (Akhter, Ali Aziz et al. 
2014, Lawson, Glenn et al. 2016, Nartey, Mazzanti et al. 2017, Gannon, 
Antonsson et al. 2018, Lawson, Salmons et al. 2018), however the 
experimental and clinical data towards a causal association of viruses and 
cancer are controversial as it is highlighted by different studies (Joshi and 
Buehring 2012, De Paoli and Carbone 2013).  The isolation of circular 
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episomal DNA agents from commercially available milk samples, healthy 
cattle blood samples and human blood and tissue led in the postulation of 
“bovine milk and meat factors” (BMMFs) being transmissible to humans and 
potentially playing a role in the pathogenesis of breast and colon cancer (zur 
Hausen, Bund et al. 2017). The authors of this review suggest that 
epidemiological data link several types of cancers, among them Hodgkin’s 
disease, as well as neurodegenerative, cardiovascular and autoimmune 
diseases with the consumption of red meat and dairy products.  
It is assumed that an infection with these agents takes place early in life, 
probably during the weaning period and by the exposure of children to the 
commercially available cow milk (zur Hausen, Bund et al. 2017). This theory is 
supported by studies indicating a highly protective role of human milk, which 
contains specific sugars apparently blocking receptors that act as binding 
sites of several agents or generally lower amounts of risk factors which are 
only present in cow products. These agents may persist latently for several 
decades and cause chronic inflammatory lesions, resulting in mutagenic 
oxygen and nitrogen radicals. BMMF activation later in life could be due to 
various yet unknown synergistic interactions, such as infection by different 
viruses from the Herpes virus family.  
A number of questions are raised based on these considerations:  
1. How can the existing epidemiological data be linked with the 
molecular biology of breast cancer?  
2. Can these agents of obviously bacterial origin replicate in 
human cells? 
3. Are these agents capable of inducing a human immune 
response? 
 
Within this thesis a previously unknown BMMF sequence was identified 
by Next Generation Sequencing (NGS) from silico breast tissue samples. 
Interestingly, it was shown that bacterially derived BMMFs can actively persist 
and replicate in human pre-B cells and that an antibody response against the 
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replication protein of BMMFs can be detected in serum samples of breast 
cancer patients. 
 
 Identification of three new BMMFs 
 
Based on epidemiological data linking the consumption of red meat 
and dairy products and the incidence of breast and colon cancer and 
neurodegenerative diseases, commercially available cow milk, bovine serum 
samples and blood and tissue samples from Multiple Sclerosis patients were 
analyzed resulting in the isolation of 18 circular DNA agents, mainly from 
bovine samples (Funk, Gunst et al. 2014, Gunst, Zur Hausen et al. 2014, 
Lamberto, Gunst et al. 2014, Whitley, Gunst et al. 2014). These molecules 
have been organized into four groups based on their nucleotide similarity to 
previously identified circular genomes. All contain a large open reading frame 
encoding for a putative replication initiator protein (rep protein). In addition, 
they reveal an A/T-rich region and four direct repeat sequences up-stream of 
the Rep ORF, characteristic for circular Replication-associated protein (Rep)-
encoded single-stranded (CRESS) DNAs (Rosario, Duffy et al. 2012). CRESS 
DNA viruses display considerable sequence diversity and their potential 
pathogenicity in certain hosts and the environment is poorly understood 
(Fernandez, Nunez-Ramirez et al. 2016).  
An important part of this PhD thesis was the continuing analysis of a 
commercially available milk samples as well as its expansion to different dairy 
products. This approach resulted in the identification of two previously 
unknown DNA agents from milk that showed similarity to one of the previously 
identified agents. In addition, three of the previously isolated agents, were 
reproductively identified in different dairy samples. The use of additional 
primers, which are specific for the BMMF group 2 isolated, has also revealed 
approximately 30 new molecules coming from different dairy products (card 
cheese, yogurt, crème fraiche) and milk samples indicating that there is 
significant diversity of such agents. Repetitive re-isolations of BMMF group 1 
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representatives might indicate less diversity for this group in milk when 
compared to BMMF2 isolations. BMMF isolation from milk and yogurt, 
representing dairy products with a longer processing phase, in general, might 
hint at significant stabilization of BMMFs surviving even longer production 
cycles and longer self-life observed for these products. Based on recently 
published data (Eilebrecht, Hotz-Wagenblatt et al. 2018), a co-infection with 
more than one of these agents might be responsible for the pathogenicity of 
BMMFs, as replication of the smaller genome MSBI1.176 was increased 
when co-transfected with the larger genome CMI1.252 in HEK293TT cells in 
comparison to the single-transfection condition of each isolate alone. In any 
case, these agents might represent novel, still not fully characterized 
pathogens and therefore their specific pathogenicity model deserves analysis 
from various aspects. 
Assuming a role of BMMF infection in direct carcinogenesis during 
breast cancer formation, the corresponding BMMF genomes might be 
identifiable by sequencing from total DNA isolated from breast cancer. It has 
been postulated that BMMFs are transferred to their target cells after initial 
infection early in life (zur Hausen, Bund et al. 2017). BMMFs were discovered 
by polymerase chain reaction (PCR) using specific primers based on 
previously characterized agents. In this thesis, a different approach was 
developed in order to de novo identify episomal DNA molecules from any type 
of sample without any prior sequence knowledge. Therefore, Next Generation 
Sequencing (NGS) was used to analyze breast cancer biopsies. Metagenomic 
approaches can detect known or unknown viruses and they do not require 
prior sequence information. This approach is highly sensitive and it can 
quickly recover full viral genome sequences with less initial material in 
comparison to the classical methods of cloning. When combined with nucleic 
acid sequence-independent amplification techniques (such as Rolling Circle 
Amplification, RCA), NGS can enhance sensitivity.  
The step of sample preparation is very crucial for downstream NGS 
approaches. Eukaryotic nucleic acids can obscure the isolation and 
identification of viral and bacterial DNA and therefore it is beneficial to remove 
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this DNA prior to sequencing. Additionally, removal of host genetic material is 
also important for increasing the detection sensitivity of the NGS platform. 
Several virus enrichment approaches have been developed over the years, 
including sequence independent single-primer amplification (SISPA), virus 
discovery cDNA-amplified fragment length polymorphism (VIDISCA) and 
RCA. The selection of an appropriate high-throughput sequencing technique 
is also essential when performing such experiments. The longer the obtained 
sequence reads, the better they can be used for de novo assembly and 
generation of contigs, enhancing the possibilities of succeeding in nucleotide 
databank searches. In addition, the analysis of the excessive amount of data 
obtained from NGS is the most demanding step of metagenomic analyses.  
Taken these aspects into account, prior to the analysis of the breast 
cancer biopsies, a protocol was established for the reliable purification of 
plasmid DNAs from tissue samples and their subsequent detection by NGS. 
Two kits, one for isolation of total DNA and one for isolation of plasmid DNA, 
were used for the DNA isolation from breast cancer tissue biopsies, followed 
by Rolling Circle Amplification (RCA) for amplification of small single-stranded 
DNAs and Plasmid-Safe DNase digestion for removal of chromosomal DNA. 
Eleven breast tissue samples and their corresponding tissue adjacent to 
tumor (TAT) samples were used for DNA isolation with both kits. However, 
due to the large amount of adipose tissue in the TAT samples and low 
amounts of DNA obtained from them with the plasmid kit, further steps of 
quality control and library preparation for NGS were performed only on the 
total DNA obtained with the other kit. A protocol for FFPE samples has been 
used for the library generation of the fourteen samples (seven breast cancer 
tumor samples and seven corresponding TAT samples) and sequencing was 
performed in a Illumina HiSeq4000 platform initiating paired-end reads of 100 
bp length.  
The bioinformatical processing was performed according to a recent 
study (Jorgensen, Xu et al. 2014). Briefly, after removal of adapter sequences 
and low quality nucleotides, the Illumina reads were mapped to the human 
genome 38. The unmapped reads were assembled de novo using IDBA-UD 
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and parameters according to the above mentioned study. Therefore implicitly 
all putative bacterial sequences which are normally filtered out by standard 
algorithms were still present in the reads. At the next step, a pipeline was 
developed to search for circular contigs, since it was expected that if a circular 
contig is sequenced with high enough coverage and assembled into a single 
contig, reads overlapping the ends of the contig should exist. The potentially 
circular contigs were mapped again to the human genome and BLAST search 
against the previously identified genomes (Funk, Gunst et al. 2014, Gunst, 
Zur Hausen et al. 2014, Lamberto, Gunst et al. 2014, Whitley, Gunst et al. 
2014) was performed. One circular contig of 1620 bp size was found in a TAT 
sample, which showed 85% similarity to the previously isolated MSSI.162 
(Gunst, Zur Hausen et al. 2014) according to BLAST search. The significant 
differences between the two genomes exclude the possibility of a laboratory 
contamination. MSSI1.162 belongs to the Group 4 of our isolates and it is 
closely related to a plasmid of the Psychrobacter. Previously tested, it showed 
substantially less transcriptional activity compared to the other isolates 
(unpublished data). This contig reveals also 95% similarity to an uncultured 
bacterial plasmid isolated from plasma of patients in maintenance 
hemodialysis (Biagini, P), raising the question whether such agents may play 
a role in the pathogenesis of other diseases as well. Interestingly, it was 
present in one of the TAT samples, which could indicate that BMMFs as 
causative agents are more prevalent in TAT than in tumor, possible due to 
lost after tumorigenesis, because no DNA replication is taking place anymore. 
Even though the breast tissue samples that have been used in this study had 
been stored for many years and subjected to several cycles of freezing and 
thawing, the success of one out of the fourteen samples analyzed suggests 
that the developed approach is adequate for the discovery of such sequences 
and that the use of fresh tissue samples could reveal more positive results in 
future attempts. 
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 Replication of BMMFs 
 
Breast cancer is not the only disease whose incidence correlates with 
the consumption of meat and dairy products. Several epidemiological data 
indicate a potential correlation between milk and read meat consumption as 
well as the animal exposure and the development of Hodgkin’s disease and 
other cancers and neurodegenerative diseases (zur Hausen, Bund et al. 
2017). In addition, 24 full-length Torque Teno virus types (a single-stranded 
DNA virus, with similar structure however different nucleic acid composition) 
have been isolated from a single spleen biopsy sample from a patient with 
Hodgkin’s lymphoma (Jelcic, Hotz-Wagenblatt et al. 2004).  
To specifically screen for a potential permissive cell culture system for 
BMMFs, two Hodgkin’s Lymphoma cell lines, the L-1236 and L-428 cell lines, 
were selected for transfection with the Multiple Sclerosis brain isolate 
MSBI1.176, which after transfection revealed the strongest transcriptional 
activity and protein expression (Eilebrecht, Hotz-Wagenblatt et al. 2018). 
These cells are considered pre-B cells (Kuppers, Rajewsky et al. 1994). Blood 
cells of the B cell lineage may transport BMMFs to the affected organ. 
Previous experiments (zur Hausen, unpublished data) showed small putative 
particles in the L-1236 cells after infection with herpes simplex virus (HSV-1), 
which may hint at specific viral infections playing a role in the pathogenesis of 
Hodgkin’s disease (reactivation by HSV-1 infection).  
After transfection of both cell lines with the MSBI1.176 genome, DNA 
was harvested at different time points. Digestion with DpnI restriction 
digestion was included before further analysis, in order to remove methylated 
input DNA while retaining non-methylated replicated DNA. However, several 
points should be taken into account for a reasonable assessment of 
replication competence: i) DpnI restriction digestion efficacy is never at 100%, 
ii) only a limited number of DpnI sites is covered by primers in qPCR 
analyses, rendering the detection of newly synthesized DNA less sensitive, 
and iii) DNA methyltransferases, a family of enzymes that catalyze the 
methylation of DNA and shifts methyl groups from one nucleotide to another, 
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can bias the restriction efficiency of the DpnI sites, interfering with the 
detection of replicated DNA. Analyses by long-PCR and qPCR showed 
persistence of the MSBI1.176 genome up to day 36 post transfection. The 
presence of newly synthesized (non-methylated) DNA pointed at replication of 
the transfected genome. Several factors may play a role in MSBI1.176 
replication, such as a specific activity of the Rep protein or of host cellular 
replicases, as well as the AT-rich region, which is a major region for 
controlling the DNA replication initiation. Further experiments with specific 
mutations and testing for responsible elements would provide more 
information. 
It has previously been reported that in co-transfection experiments of 
HEK293TT cells with MSBI1.176 and CMI1.252 genomes (Eilebrecht, Hotz-
Wagenblatt et al. 2018), CMI1.252 complements the replication of MSBI1.176. 
However, this effect was not observed during co-transfection of the L-428 
cells with these genomes potentially due to the high rate of MSBI1.167 
replication already in the single transfection or due to differences in 
transcriptional activity between the different cell lines. Translational 
differences or transfection efficiency could also influence the outcome. 
CMI1.252 showed stable replication up to 28 days post transfection in this cell 
line as well, similar to the replication of TTVs in 293TT cells (Borkosky, 
Whitley et al. 2012) and similar to CMI1.252 replication in HEK293TT cells 
(Eilebrecht, Hotz-Wagenblatt et al. 2018). 
Very interestingly, within routine replication experiments additional 
repeatedly-observed bands were identified. Further co-transfection 
experiments involved the transfection with small genomes of 613 bp length, 
isolated after transfection of L-428 cells with MSBI1.176. Long-PCR on DpnI 
digested DNA revealed these small extra bands representing the MSBI1.176 
genome with substantial deletions (at 1700 bp for MSBI1.176). These 
molecules may also arise from defective replication of the initial genome. In 
order to test for potential functional importance of these molecules, replication 
and stability were investigated and they were tested for regulatory effects. 
These molecules might have an interfering or helper effect during replication 
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of the MSBI1.176 genome from which they originated. Such an effect is 
established for Begomoviruses, a genus of the family of Geminiviruses (plant 
animals with circular, single-stranded DNA genome of ~ 2.7 kb) that their 
genome is accompanied by small circular satellite DNAs, which can replicate 
autonomously or transreplicate by their non-cognate helper virus (Rosario, 
Duffy et al. 2012, Hanley-Bowdoin, Bejarano et al. 2013, Rizvi, Choudhury et 
al. 2015). In the case of MSBI1.176 sg613, the structure and autonomous 
replication, as well as any helper or regulatory effect for DNA replication of the 
small isolated genome were analyzed. This genome consists of the last part 
of the repeat region up stream of the Rep ORF and continues covering 
approximately 2/3 of the latter, remained stable in this rearranged form (de 
Villiers, unpublished).  Analysis of the DpnI-persistent DNA by long PCR and 
qPCR revealed that this small genome is capable of independent replication, 
suggesting that only the last iteron of the repeat region or control elements in 
the residual sequence might be sufficient to initiate replication. It remains 
elusive whether the C-terminus of the Rep protein, which is lacking in the 
sg613, plays a role in aggregation formation and replication. Interestingly, 
Torque-Teno viruses (TTVs) of approximately 1000 bp length have also 
shown to persist in different cell lines for more than 28 days post transfection 
(de Villiers, unpublished data). However, in the L-428 cell line, no clear effect 
was observed after co-transfection with the small genome and MSBI1.176, 
indicating that the minimized genome is competent of autonomous replication, 
but any competition role with the full length MSBI1.176 genome requires 
further investigation. It would also be important to test whether different parts 
of the iterons might affect replication of MSBI1.176 in an abortive or 
productive way, possibly by an induction of a Rep dimerization-
monomerization process, since it has been demonstrated that the binding of 
short dsDNA oligonucleotides including the iterons affects the winged-helix 
WH1 domain of the Pseudomonas pPS10 plasmid promoting the assembly of 
different structures (such as aggregates and amyloid spheroids) instead of the 
usual monomerization that takes place and leading to an inhibition of  plasmid 
replication (Fernandez, Nunez-Ramirez et al. 2016).   
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 Study of Neu5Gc glycoproteins and phenotypic characterization 
 
As replication of BMMFs in pre-B cells was proven, the next question 
dealt with potential cellular receptors mediating a BMMF infection. It has 
already been reported that the incorporation of N-glycolylneuraminic acid 
(Neu5Gc) into human cell glycoprotein receptors leads to chronic 
inflammatory reactions.  This has led to a model, in with such a Neu5Gc 
incorporation potentially promotes cancer and other diseases (Alisson-Silva, 
Kawanishi et al. 2016). Neu5Gc cannot be synthesized in humans due to an 
exon deletion in the enzyme responsible for the formation of Neu5Gc from its 
precursor sialic acid N-acetylneuraminic acid (Neu5Ac). Neu5Gc is 
metabolically incorporated via dietary consumption specifically of red meat 
and cow milk. A recent publication (zur Hausen, Bund et al. 2017) 
summarizes a number of reasons supporting the theory that a functional 
receptor for BMMFs is established by Neu5Gc incorporation. These include 
reports that Neu5Gc acts as a specific receptor for several viruses, like 
human polyoma virus 9, canine and fenine parvoviruses, types of influenza A 
and parainfluenza viruses. In order to test an involvement of Neu5Gc in 
increasing the permissiveness of human cells for BMMF replication, we 
compared a condition of MSBI1.176 transfection with external addition of 100 
μM free Neu5Gc (approximately 100-fold excess compared to the standard 
Neu5Gc in 10% FCS cell culture medium) with one without addition. However, 
no significant difference in MSBI1.176 genome replication was detected.  
Furthermore, infection experiments of fresh cells with MSBI1.176-
positive supernatants of MSBI1.176-transfected cells were performed from the 
first time in a further attempt to test an involvement of Neu5Gc and to 
establish a general infection system for BMMFs, but no infectivity was 
observed. These negative results might be due to the experimental setting 
used, since it disregarded the presence of Neu5Gc in fetal calf serum added 
to the cell culture, which might repress the binding of the particles to the 
receptors by binding to the particle surface. In addition, with this setting there 
is no direct contact of the target and producer cells and there is a long time of 
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separation of production of viral particles and infection of fresh cells, while at 
the same time centrifugation and filtering steps cause general instability and 
loss of viral particles. Furthermore, the freezing and thawing steps of 
supernatants might have already affected the stability of protein particles and 
vesicles, which might decrease infectivity. Therefore, infectivity of BMMFs still 
remains an open question and a more appropriate experimental set-up could 
provide conclusive answers for a potential role of Neu5Gc-modified receptors 
for infectivity of BMMFs. In addition, focusing on different combinations of 
agents and not on single MSBI1.176 infections might provide useful 
information and broaden our knowledge about the role of these agents in 
human diseases.  
Expression/replication of putative pathogens phenotypic 
characterization is important. It has already been reported that several 
cancer-related genes are significantly regulated by MSBI1.176 and CMI1.252, 
suggesting a potential link of BMMFs to cellular pathways damaged during 
carcinogenesis (Eilebrecht, Hotz-Wagenblatt et al. 2018). Cell viability and cell 
proliferation assays allow the monitoring of cell growth progression in vitro 
and provide multiplexed information about cell cycle duration, transition 
points, proliferative quiescence, etc. (Simone, T. et al. 2009). The main focus 
was to test for differences in cell viability and recovery as well as to determine 
cell health upon BMMF genome transfection. Over-expressed proteins, wild 
type and aggregation mutant of MSBI1.176 Rep protein, were used as 
controls. No phenotypic changes were observed with either of the 
approaches. Besides, when these agents act as indirect carcinogens, no 
phenotypic changes should emerge. The absence of phenotypic changes 
indicates that there is no difference between the two over-expressed 
genomes upon transfection and that the function/activity of Rep protein 
expression does not play a pivotal role in manifestation of phenotypic changes 
of viability and cell progression. This result could also be an effect of the 
promoter used (in this case cytomegalovirus, CMV) which is a strong one and 
potentially affects cell proliferation. The use of a different promoter is 
recommended for future experiments, such as the human Ubiquitin C 
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promoter (UBC) or the mouse phosphoglycerate kinase 1 promoter (PGK), as 
well as the use of different DNA amounts used for transfection.  
 
 
 MSBI1.176 Rep antibody response in human serum samples 
 
Transcription, translation and replication are important aspects of 
bioactive pathogens. The expression of the corresponding antigens in the 
host will then raise an immune response consisting of a production of antigen-
specific antibodies. Thus, bioactivity of pathogens might also be deduced from 
the detection of specific host antibodies targeting the putative infectious 
agents, indicating that human individuals have been exposed to such agents. 
An involvement of BMMFs in breast cancer or Hodgkin’s disease 
etiology should lead to a detectable immune response to those agents 
specifically in patients suffering from the respective disease. In this case 
elevated antibody titers directed against BMMF gene products in sera of 
disease patients would be expected compared to healthy controls. Therefore, 
sera from patients with breast cancer and Hodgkin’s Lymphoma were 
analyzed by ELISA assays in order to identify a potential immune response of 
these patients against the Rep protein of the MSBI1.176 isolate.  
Although a detectable immune response against the MSBI1.176 Rep 
antigen was observed in Hodgkin’s disease samples, the signal intensity was 
low compared to other cohorts and no statistically significant difference was 
observed between the patients and the healthy controls This decreased 
antibody levels might hint at no immunogenicity of BMMFs or at possible 
partial immunotolerance due to a very early acquisition of these types of 
infections. On the other hand, breast cancer serum samples revealed a 
significant difference (P = 0,010) when compared to healthy plasma controls, 
supporting the theory of an infection with BMMF-like agents early in life and 
neutralizing antibody formation. However, these results have to be 
                            Discussion 
 
95 
 
reproduced comparing breast cancer serum samples with serum samples of 
matched healthy controls, in order to rule out that the observed differences in 
immune response result from the comparison of plasma with serum.  
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Conclusions 
 
Epidemiological data indicate a potential relation between the 
consumption of bovine meat and dairy products and the incidence of breast 
cancer and colon cancer, as well as neurodegenerative diseases. A model in 
which species-specific risk factors might contribute to the etiology of such 
diseases has been reported (zur Hausen and de Villiers 2015). Based on this 
model, circular DNA molecules have been isolated from commercially 
available milk and dairy products during this study. In addition, the isolation of 
a similar molecule, following a High Throughput Sequencing protocol that has 
been developed as part of this thesis, from a tissue sample adjacent to breast 
cancer tissue opens new starting points for investigation and analysis. 
This study established a long-term persistence and replication of a set 
of bacterial-derived plasmid-like agents in two Hodgkin’s disease-derived cell 
lines. Co-transfection experiments with more than one agent failed to prove 
regulatory effects in these cell lines likely to already individual replication 
levels, even though helper effects for two of them has been shown previously 
by our group in a different cell line (Eilebrecht, Hotz-Wagenblatt et al. 2018).  
The demonstration that the incorporation of Neu5Gc into human cell 
membranes can cause an immune reaction leading to chronic inflammation 
steered the model of a potential role of Neu5Gc as receptor for BMMF 
infection, especially since it has already been reported that it acts as receptor 
for several viruses. The experiments performed in this study only showed a 
slight increase of replication after external addition of Neu5Gc, but they did 
not serve conclusive results regarding infectivity of BMMFs and additional 
investigations under different conditions are required.  
Finally, the elevated anti-MSBI1.176 Rep immune response detected in 
sera from breast cancer patients compared to healthy donors indicated that 
infection with BMMF related agents resulted in neutralizing antibody 
formation.  
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This PhD thesis focuses on an epidemiologically suggested 
involvement of dietary habits as a risk factor for the formation of breast cancer 
and provides important information on a new and yet unknown field. However, 
there are still open questions that will require additional studies.    
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5. Summary 
 
Breast cancer is the second-leading cause of cancer-related deaths in 
women worldwide. A number of factors are associated with an increased risk 
of the disease. Epidemiological data indicate a potential link between the 
consumption of bovine meat and dairy products and the incidence of breast 
cancer, as well as other types of cancer such as colon and prostate cancer 
and neurodegenerative or autoimmune diseases. Analysis of the 
epidemiological data led to the suggestion of a new theory introducing a 
putative role of species-specific factors originating from the species Bos 
taurus contribute to the etiology of these diseases. Based on these 
speculations, our group started analyzing bovine serum samples, 
commercially available milk, as well as human blood and tissue samples from 
Multiple Sclerosis patients. This study resulted in the isolation of 18 circular 
DNA agents, so called Bovine Meat and Milk Factors (BMMFs), which have 
been divided in four groups according to their similarity to known DNA 
molecules. This PhD thesis focused on continuing this study, by expanding it 
in different dairy products such as yogurt, crème fraiche, butter and card 
cheese, resulting in the isolation of two novel DNA molecules which share 
similarity to some extend with the MSBI1.176 isolate.  
In addition to the classical molecular biology-based DNA isolation 
techniques, also isolation of DNA from breast cancer tissue samples by Next 
Generation Sequencing (NGS) was performed. A protocol was established for 
the reliable purification of plasmid DNAs from mammalian cells. DNA from 
seven breast cancer tissue samples and their corresponding Tissue Adjacent 
to Tumor (TAT) samples was analyzed by NGS resulting in the isolation of a 
circular DNA molecule from a TAT sample, which showed 85% nucleotide 
identity to the previously isolated MSSI1.162 and 95% similarity to an 
uncultured bacterium plasmid isolated from plasma of patients in maintenance 
hemodialysis. This discovery sets new starting points for further investigation 
and analysis.  
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Epidemiological data suggest a potential link between the consumption 
of red meat and animal exposure and the incidence of Hodgkin’s disease, 
while in the past 24 full-length Torque Teno viruses (a single stranded DNA 
virus) have been isolated from the spleen biopsy of a single patient with 
Hodgkin’s lymphoma. Therefore, searching for a permissive cell system for 
the identified BMMFs, two Hodgkin’s disease cell lines, the L-1236 and L-428, 
were selected for transfection and long-term persistence and replication of a 
set of bacterially-derived plasmid-like agents was established. Co-transfection 
experiments with more than one agent failed to prove complementation 
effects in these cell lines, even though helper effects for two of them have 
been shown previously by our group in the HEK293TT cell line. 
The demonstration that the incorporation of N-Glycolylneuraminic acid 
(Neu5Gc) into human cell membranes can cause an immune reaction leading 
to chronic inflammation steered the model of a potential role of Neu5Gc as 
receptor for BMMF infection, especially since it has already been reported that 
it acts as receptor for several viruses. The experiments performed in this 
study only showed a slight increase of replication after external addition of 
Neu5Gc, but they did not serve conclusive results regarding infectivity of 
BMMFs and additional investigations under different conditions are required.  
Finally, sera from breast cancer and Hodgkin’s disease patients were 
analyzed by ELISA assays in order to identify a potential immune reaction of 
those patients against the Rep protein of MSBI1.176. The elevated anti-
MSBI1.176 Rep immune response detected in sera from breast cancer 
patients compared to plasma from healthy donors indicated that infection with 
BMMF related agents resulted in measurable antibody formation. However, 
no difference in seropositivity was observed when serum samples from 
patients suffering from Hodgkin’s lymphoma where compared to healthy 
plasma samples.     
This PhD thesis focuses on an epidemiologically suggested 
involvement of dietary habits as a risk factor for the formation of breast cancer 
and provides important information on a new and yet unknown field. However, 
there are still open questions that require further studies.  
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Zusammenfassung 
Brustkrebs ist die zweithäufigste Ursache Krebs-assoziierter Todesfälle 
bei Frauen weltweit. Viele verschiedene Faktoren sind mit diesem 
Krankheitsrisiko assoziiert. Epidemiologische Daten deuten auf eine 
potenzielle Verbindung zwischen dem Verzehr von Rindfleisch als auch 
Milchprodukten und der Brustkrebsinzidenz hin, wobei auch andere Arten von 
Krankheiten wie sowohl Dickdarm- und Prostatakrebs als auch 
neurodegenerative oder Autoimmundefekte damit in Verbindung gebracht 
werden. Aufgrund der epidemiologischen Daten wurde eine neue Hypothese 
aufgestellt, die Rinderarten, die sich aus der Gattung Bos taurus ableiten, 
einen spezies-spezifischen Faktor zuschreibt. Dieser Faktor sollte für die 
Ätiologie der genannten Krankheiten (mit)verantwortlich sein. Darauf 
aufbauend analysierte unsere Arbeitsgruppe sowohl Rinderseren und 
kommerzielle Milchproben wie auch humanes Blut und Gewebe von Patienten 
mit Multipler Sklerose. In dieser Studie wurden 18 zirkuläre DNA-Moleküle 
isoliert, genannt bovine milk and meat factor (BMMF), die aufgrund ihrer 
Sequenzähnlichkeit zu bereits bekannten DNA Molekülen in vier 
Untergruppen klassifiziert wurden. Diese Dissertation führt DNA-Isolationen 
fort, indem weitere Milchprodukte wie Joghurt, Creme Fraiche, Butter und 
Quark untersucht wurden. Hieraus konnten zwei neue DNA-Moleküle isoliert 
werden, die eine Ähnlichkeit zu einem bereits aus früheren Studien bekannten 
Molekül zeigen (MSBI1.176).  
Zusätzlich zur klassischen molekularbiologischen Isolation und Analyse 
von DNA wurden hier Brustkrebsgewebe mittels „Next-Generation-
Sequenzierung“ (NGS) auf das Vorhandensein von BMMFs getestet. Dafür 
wurde ein reproduzierbares Protokoll zur Aufreinigung von Plasmid-DNA aus 
Säugetierzellen etabliert. Die so gewonnene DNA aus sieben 
Brustkrebsgeweben und gesundem Tumor-benachbarten Kontrollgewebe 
wurde mittels NGS analysiert. Aus diesem Kontrollgewebe wurde ein 
zirkuläres DNA Molekül isoliert, welches 85% Sequenzidentität auf 
Nukleinsäureebene zu einem bereits aus erster Studie bekanntem Isolat 
MSSI1.162, zeigt und auch 95% Ähnlichkeit zu einem bakteriellen Plasmid 
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eines Hämodialyse-behandelten Patienten aufweist. Dies zeigt neue und 
interessante Ansätze für weitere Untersuchungen auf.  
Epidemiologische Daten legen auch eine potenzielle Verbindung 
zwischen dem Verzehr und der verstärkten Exposition mit rotem Fleisch und 
Hodgkin Lymphomen nahe. Darüber hinaus wurden in der Vergangenheit 24 
Torque-Tenoviren (einzelsträngige DNA Viren) aus Milzbiopsien eines 
Hodgkin Lymphom-Patienten isoliert. Daher wurden für die Suche nach einem 
permissiven Zellkultursystem für die identifizierten BMMFs zwei Zelllinien, die 
ursprünglich aus Hodgkin-Lymphomen stammen, getestet (L-1236 und L-
428). Nach transienter Transfektion dieser Zelllinien konnte eine Langzeit-
Persistenz und Replikation der verschiedenen Plasmid-ähnlichen Agenzien in 
diesen beiden Zelllinien aufgezeigt werden. In Ko-Transfektionsexperimenten 
mit Kombinationen zweier unterschiedlicher BMMFs wurde jedoch keine 
Komplementation der Agenzien in Hodgkin Zelllinien beobachtet, obwohl 
solche Helfereffekte in der Nierenzelllinie HEK293TT in unserer Arbeitsgruppe 
gezeigt wurden.    
Der Einbau des Zuckermoleküls N-Glycolylneuraminsäure (Neu5Gc) in 
humane Zellmembranen kann Immunreaktionen und dadurch chronische 
Entzündungen verursachen. Darüber hinaus dient es als Rezeptor für 
verschieden Viren, weshalb Neu5GC eine potenzielle Rolle im Zelleintritt der 
BMMFs spielen könnte. Die durchgeführten Experimente zeigten allerdings 
nur eine geringe Verstärkung der Replikation nach externer Zugabe von 
Neu5GC. Daher lassen sich keine eindeutigen Schlüsse bezüglich der 
Infektion von BMMFs ziehen und weitere Untersuchungen unter 
verschiedenen Bedingungen sind hierzu nötig.  
Um eine potenzielle Immunreaktion von Patienten mit Brustkrebs und 
Hodgkin Lymphomen gegenüber dem MSBI1.176-BMMF kodierten Rep-
Protein zu untersuchen, wurden ELISA-Experimente durchgeführt. Es wurde 
eine erhöhte Immunantwort gegenüber MSBI1.176 Rep in Serum von 
Brustkrebspatienten gegenüber Plasma von gesunden Probanden 
festgestellt, was eine messbare Exposition gegenüber BMMF zeigt. Allerdings 
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konnte kein Unterschied der Seropositivität zwischen Serum von Patienten 
mit Hodgkin-Lymphom und Kontrollplasma beobachtet werden.  
Diese Dissertation untersucht eine epidemiologisch basierte Assoziation von 
diätetischen Gewohnheit als Risikofaktor bei Brustkrebs. Es wurden wichtige 
Erkenntnisse auf diesem bisher unbekannten Gebiet gewonnen, wobei 
weitere Studien nötig sind um BMMF eindeutig mit Brustkrebs in Verbindung 
zu bringen.   
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Appendix 
 
A. List of abbreviations 
BSA bovine  serum albumin 
oC degree Celsius  
DMSO dimethylsulfoxid 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP deoxynucleotide triphosphate 
E.coli Escherichia coli 
et al. and others (et alii) 
EtOH ethanol 
FCS fetal calf serum 
FFPE formalin-fixed paraffin-embedded 
Fig. Figure 
g gram 
IPTG isopropyl-β-D-thiogalactopyranoside 
kb kilo bases 
LB Luria-Bertani 
m milli 
M molar 
µ micro 
min minute 
n nano 
NCBI National Centre of Biotechnology 
NEB New England Biolabs 
NGS Next Generation Sequencing 
PAGE polyacrylamide gel-electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
pH preponderance of hydrogen ions 
phi29Pol 29 polymerase 
PNK polynucleotide kinase 
qPCR quantitative polymerase chain reaction 
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RCA rolling circle amplification 
RNA ribonucleic acid 
rpm rounds per minute 
SDS sodium dodecyl sulfate 
sec seconds 
Taq Thermus aquaticus 
TBE Tris/Borate/EDTA 
Tris Tris-(hydroxymethyl)-aminoethan 
UV ultraviolet 
V volt 
v / v volume per volume 
w / v weight per volume 
www world wide web 
X-Gal 5-Brom-4-chlor-3-indoxyl-β-D-
galactopyranosid 
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B. Laboratory equipment 
Equipment Model Supplier 
Centrifuge 5415D Eppendorf 
Vortex Genie2TM Bender & Hobein AG 
Rotator   
Lyophilization machine   
Mixer 5432 Eppendorf 
Centrifuge  Sigma 2k15 SIGMA 
Water bath Julabo MP JULABO 
Electrophoresis power 
supply 
GibcoBRL PS 305 Life Technologies 
Thermocycler FlexCycler2 Analytik Jena 
Centrifuge Megafuge 1.0 Heraeus instruments 
Centrifuge Megafuge 1.0R Heraeus instruments 
Microprocessor pH meter pH 537 WTW 
Magnetic stirrer REO Drehzahl-electronic IKA IKAMAG 
Shaker Rocker25 Labnet 
Shaking water bath Type 3047 Kottermann 
Laminar flow hood SAFE2020 Thermo Scientific 
CO2 incubator C200 Labotect 
Blot imager Chemidoc Touch Imaging 
System 
Bio-Rad 
Multimode plate reader EnSpire PerkinElmer 
Real-Time PCR system QuantStudio 5 Applied Biosystems 
Gel documentation system Molecular Imager Gel Doc 
XR 
Bio-Rad 
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UV light plate N90 LW 366 nm Konrad Benda 
Incubation shaker Multitron Pro INFORS HT 
Material test chamber Material test chamber FP 53 BINDER 
Centrifuge RC-5C Sorvall 
Transfer system  Trans-Blot Turbo Bio-Rad 
Spectrophotometer Nanodrop2000 Thermo Scientific 
Zeiss cell observer   
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C. List of dairy products used for DNA isolation 
 
Type of product Product name Name in the 
lab 
Yoghurt Bombay Lassi Mango - Giacomo mi5 
 Gut and Günstig - EDEKA  mi6 
Milk Gut and Günstig, Vollmilch, DE HE013 Eg mi7 
 Unsere Heinat, Bio Vollmilch, demeter, 
Heumilch, Milch ab BW, Wongen 
mi8 
 Schwälbehen, Bad Schwalbah, Vollmilch mi9 
 Schwartwaldmilch, Bio Vollmilch, Fräburg mi10 
 Berchtesgardener Land, Frishe Bergbavern, 
Milch 
mi15 
 Weihen stephan, Frische Milch 3.5%, 
Freising 
mi16 
Crème fraîche Gut and günstig, Crème fraiche, EDEKA mi11 
 Demeter, Bio - crème fraiche, 
Berchtesgardener Land 
mi12 
Quark Speisequark, 40%, Scwälbchen mi13 
 QUARK, 40%, Ehrmann mi14 
Butter Irische Butter, Schüttent Lemmerholtz, 
414b8 Neuss 
mi15 
 Weihenstephan, Butter mi16 
 
  
                             
 
118 
 
D. Supplemented figures and tables 
 
Figure S1 CLUSTAL alignment of putative replication proteins of BMMF1 including 
the newly isolated CMI5.170 and CMI5.240. 
 
 
Figure S2 CLUSTAL alignment of putative replication proteins of MSSI1.162, 
7717N_contig sequence isolated from breast tissue and the plasmid isolated from 
Biagini (KX838914). 
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Table S1  Information on breast cancer serum patients. 
 
 
Table S2  Age and sex information of the plasma samples tested. 
Number Age Sex 
 
Number Age Sex 
1 21 ♀ 
 
18 22 ♂ 
2 27 ♂ 
 
19 20 ♀ 
3 22 ♀ 
 
20 27 ♂ 
4 23 ♂ 
 
21 26 ♀ 
5 22 ♂ 
 
22 26 ♂ 
6 26 ♂ 
 
23 20 ♂ 
7 23 ♂ 
 
24 29 ♂ 
8 30 ♂ 
 
25 23 ♂ 
9 25 ♂ 
 
26 27 ♂ 
10 30 ♂ 
 
27 20 ♂ 
11 23 ♀ 
 
28 40 ♀ 
12 21 ♀ 
 
29 20 ♀ 
13 32 ♀ 
 
30 56 ♀ 
14 22 ♂ 
 
31 22 ♀ 
15 22 ♂ 
 
32 24 ♂ 
16 23 ♀ 
 
33 58 ♂ 
17 63 ♂ 
 
34 23 ♀ 
Pat. ID Age Right breast Left breast
MaCa 001 53 Invasiv-lobuläres Mammakarzinom
MaCa 002 69 bifokales Invasiv-duktales Mammakarzinom  Invasiv-duktales Mammakarzinom
MaCa 003 67 Invasiv-duktales Mammakarzinom
MaCa 004 55 Invasiv-duktales Mammakarzinom rechts
MaCa 005 57 Multifokales Invasiv-lobuläres Mammakarzinom
MaCa 006 71 Invasiv-duktales Mammakarzinom Rezidiv rechts
MaCa 007 73 Invasives Mammakarzinom, spezieller Typ links
MaCa 008 49 multifokales Invasiv-lobuläres Mammakarzinom links
MaCa 009 68 Invasiv-lobuläres Mammakarzinom Zweitkarzinom links
MaCa 010 32 Invasives Mammakarzinom links, NST, G3, pN0
MaCa 011 30 medullärem Mammakarzinom
MaCa 012 43 Invasiv-duktales Mammakarzinom rechts
MaCa 013 45 Tubuläres Mammakarzinom
MaCa 014 50 Muzinöses Mammakarzinom rechts Rezidiv
MaCa 015 81 invasives Mammakarzinom NST links 
MaCa 016 77 Invasiv-duktales Mammakarzinom rechts
MaCa 017 77 Invasiv-duktales Mammakarzinom rechts
MaCa 018 52 Invasiv-duktales Mammakarzinom rechts
MaCa 019 60 Invasiv-duktales Mammakarzinom rechts
MaCa 020 56 Invasives Mammakarzinom links
MaCa 021 50 Invasiv-duktales Mammakarzinom links
MaCa 022 52 Invasiv-duktales Mammakarzinom links
MaCa 023 54 Muzinöses Mammakarzinom links
MaCa 024 85 Invasiv-lobuläres Mammakarzinom links
MaCa 025 54 Primär ossär metastasiertes invasiv-duktales Mammakarzinom links
MaCa 026 50 bifokales Invasiv-lobuläres Mammakarzinom links
MaCa 027 48 Invasiv-lobuläres Mammakarzinom rechts
MaCa 028 28 Invasiv-duktales Mammakarzinom rechts
MaCa 029 64 Invasiv-duktales Mammakarzinom rechts
MaCa 030 59 Invasiv-duktales Mammakarzinom links
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Table S3 Information about reads obtained after sequencing and the 
corresponding barcode of each library sample. 
 
 
E. List of figures 
Figure 1.1 Global estimated incidence of colon (A) and breast cancer (B), 
GLOBOCAN 2012 (IARC). High risk regions for cancer incidence are shown in dark 
blue color and show similarity for the two types of cancer and the same applies for 
low risk counties indicated with light blue color. 
 
Figure 1.2 Schematic view of the novel episomal circular DNAs isolated from milk, 
bovine serum and tissue and blood samples from MS patients (adapted from zur 
Hausen, Bund and de Villiers 2017).  
 
Figure 1.3 Genetic diversity of CRESS-DNA viruses. Comparison of the Rep 
sequences of more than 600 CRESS-DNAs with 10 representative Rep sequences 
from viruses classified in the families Gemonoviridae, Geminiviridae, Nanoviridae 
and Circiviridae, and a group of alha satellites that are associated with geminiviruses 
SAMPLE_ID READ_COUNT BARCODE SAMPLE_ID READ_COUNT BARCODE
7714T 71612013 ATCACG 7714N 22717321 GATCAG
7714T 71612013 ATCACG 7714N 22717321 GATCAG
7715T 19112680 CGATGT 7715N 19255549 TAGCTT
7715T 19112680 CGATGT 7715N 19255549 TAGCTT
7716T 26206563 TTAGGC 7716N 17852234 GGCTAC
7716T 26206563 TTAGGC 7716N 17852234 GGCTAC
7717T 21383940 TGACCA 7717N 30507604 GTGAAA
7717T 21383940 TGACCA 7717N 30507604 GTGAAA
7718T 25962669 ACAGTG 7718N 26082825 ACTGAT
7718T 25962669 ACAGTG 7718N 26082825 ACTGAT
7722T 30303146 CAGATC 7722N 28414396 GCCAAT
7722T 30303146 CAGATC 7722N 28414396 GCCAAT
7724T 22709478 ACTTGA 7724N 27526352 CTTGTA
7724T 22709478 ACTTGA 7724N 27526352 CTTGTA
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or nanoviruses and representation with phylogenetic tree showing the similarity 
among the different viruses in amino acid level (Simmonds, Adams et al. 2017). 
Figure 2.1 DNA ladder for agarose gel electrophoresis (GeneRulerTM DNA Ladder 
Mix, ready-to-use, Thermo Scientific). 
Figure 2.2 Page RulerTM Prestained Protein Ladder (Fermentas).  
Figure 3.1 Long-PCR with specific primers on DNA isolated from commercially 
available yogurt and milk samples after RCA. A) Bands obtained with the NnXn 
primers and B) bands obtained with the NoXo primers. The obtained molecules were 
cloned and sequenced. 
 
Figure 3.2 Circular representation of the newly isolated agents CMI5.170 and 
CMI5.240. The Rep protein is represented in pink, the additional open reading frame 
of the CMI5.240 is indicated in blue and the green line indicates the conserved 
repeat region upstream of the Rep open reading frame. 
 
Figure 3.3 ClustAL W dendogram showing the similarity of the BMMF1 group and 
the newly isolated CMI5.170 and CMI5.240.  
  
Figure 3.4 CLUSTAL alignment of the repeat region of the BMMF1 group and the 
newly isolated CMI5.170 and CMI5.240. 
 
Figure 3.5 Long-PCR on DNA extracted from placenta tissue with indicated amounts 
of pUC19 plasmid using pUC19-specific primers and comparing different sample 
preparation techniques. The band intensity reduces as the amount of pUC19 reduces 
for the plasmid kits, while it remains stable for the DNeasy kit. The observed 
difference between the conditions of 200 fg and 100 fg of pUC19 in the 
phenol/chloroform extraction was due to technical problems in the long-PCR. 
 
Figure 3.6 RT-qPCR data representing the enrichment of pUC19 plasmid DNA in 
each extraction method before and after RCA as well as after RCA upon Plasmid-
Safe DNase digestion. A region within the beta actin gene was amplified in parallel 
for each sample using specific primers, in order to control for the amount of input 
DNA. 
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Figure 3.7 RT-qPCR data representing the enrichment of Nanoluc plasmid DNA in 
each extraction method before and after RCA as well as after RCA upon Plasmid-
Safe DNase digestion. A region within the beta actin gene was amplified in parallel 
for each sample using specific primers, in order to control for the amount of input 
DNA. 
Figure 3.8 A) Circular representation of the contig found in breast NAT tissue 
sample. B) Alignment of the circular contig with the previously isolated MSSI1.162 
and the plasmid gene isolated from Biagini (KX838914). 
 
Figure 3.9 PCR with specific back-to-back primers on the seven breast tumor tissue 
samples (7714T-77124T) and the corresponding NAT controls (7714N-7724N) 
confirming the presence of the new isolate only in the expected (7717N) sample with 
approximately 1600 bp size.  
 
Figure 3.10 A) PCR after DpnI digestion on DNA extracted from L-1236 cells after 
transfection with MSBI1.176 using MSBI1.176-specific back-to-back primers. Circular 
MSBI1.176 was used as a template for a positive control reaction and DpnI-digested 
circular MSBI1.176 was used as a template for a negative control reaction. B) qPCR 
data representing the number of MSBI1.176 molecules per cell at different harvesting 
time points of L-1236 cells. A region within the beta actin gene was amplified in 
parallel for each sample using specific primers, in order to control for the amount of 
input DNA. C) qPCR data representing the ratio of MSBI1.176 DpnI digested DNA to 
MSBI1.176 non-DpnI digested DNA at different harvesting time points of L-1236 
cells. A region within the beta actin gene was amplified in parallel for each sample 
using specific primers, in order to control for the amount of input DNA. 
 
Figure 3.11 A) PCR after DpnI digestion on DNA extracted from L-428 cells after 
transfection with MSBI1.176 using MSBI1.176-specific back-to-back primers. Circular 
MSBI1.176 was used as a template for a positive control reaction and DpnI-digested 
circular MSBI1.176 was used as a template for a negative control reaction. B) RT-
qPCR data representing the number of MSBI1.176 molecules per cell at different 
harvesting time points of L-428 cells. A region within the beta actin gene was 
amplified in parallel for each sample using specific primers, in order to control for the 
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amount of input DNA. C) RT-qPCR data representing the ratio of MSBI1.176 DpnI 
digested DNA to MSBI1.176 non-DpnI digested DNA at different harvesting time 
points of L-428 cells. A region within the beta actin gene was amplified in parallel for 
each sample using specific primers, in order to control for the amount of input DNA. 
 
Figure 3.12 RT-qPCR data representing the number of CMI1.252 molecules per cell 
at different harvesting time points of L-1236 cells. A region within the beta actin gene 
was amplified in parallel for each sample using specific primers, in order to control for 
the amount of input DNA.  
 
Figure 3.13 PCR after DpnI digestion on DNA extracted from L-428 cells after 
transfection with sg613 using sg613-specific back-to-back primers. Circular 
MSBI1.176 and sg613 were used as template for a positive control reaction and 
DpnI-digested circular MSBI1.176 and sg613 were used as template for a negative 
control reaction. 
 
Figure 3.14 A) PCR after DpnI digestion on DNA extracted from L-428 cells after 
transfection with MSBI1.176 and co-transfection with MSBI1.176 and sg613 using 
MSBI1.176-specific back-to-back primers. Circular MSBI1.176 and sg613 were used 
as template for a positive control reaction and DpnI-digested circular MSBI1.176 and 
sg613 were used as template for a negative control reaction. B) RT-qPCR data 
representing the number of MSBI1.176 molecules per cell at different harvesting time 
points of L-428 cells for the single MSBI1.176 condition and the co-transfection with 
sg613. A region within the beta actin gene was amplified in parallel for each sample 
using specific primers, in order to control for the amount of input DNA. C) RT-qPCR 
data representing the ratio of MSBI1.176 DpnI digested DNA to MSBI1.176 non-DpnI 
digested DNA at different harvesting time points of L-428 cells for the single condition 
of MSBI1.176 and the co-transfection with sg613. A region within the beta actin gene 
was amplified in parallel for each sample using specific primers, in order to control for 
the amount of input DNA. 
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Figure 3.15 A) PCR after DpnI digestion on DNA extracted from L-1236 cells after 
transfection with MSBI1.176 and MSBI1.176 with external addition of 100 μM 
Neu5Gc using MSBI1.176-specific back-to-back primers. Circular MSBI1.176 was 
used as a template for a positive control reaction and DpnI-digested circular 
MSBI1.176 was used as a template for a negative control reaction. B) qPCR data 
representing the number of MSBI1.176 molecules per cell at different harvesting time 
points of L-1236 cells with and without addition of external Neu5Gc. A region within 
the beta actin gene was amplified in parallel for each sample using specific primers, 
in order to control for the amount of input DNA. 
Figure 3.16 PCR analysis of DNA extracted from supernatants collected after 
transfection of L-1236 cells with MSBI1.176 and MSBI1.176 pre-treated with Neu5Gc 
after day 3 post transfection and at each harvesting time point using MSBI1.176-
specific back-to-back primers. Circular MSBI1.176 was used as a template for a 
positive control reaction. Transfection with pUC19 vector and 1xTE buffer were used 
as negative control reactions. 
Figure 3.17 PCR on DNA extracted from L-1236 cells after infection with 
supernatants from transfection with MSBI1.176 and controls using MSBI1.176-
specific back-to-back primers. Circular MSBI1.176 was used as a template for a 
positive control reaction. The red color letters indicate the conditions with 100-fold 
excess of Neu5Gc and the green color the ones without addition of external Neu5Gc. 
Figure 3.18 Luminescent signal after transfection of L-428 cells with pcDNA3.1(-) 
control vector, MSBI1.176 Rep WT OE, MSBI1.176 Rep MUT OE, MSBI1.176 linear 
and MSBI1.176 circular genome measured at three different time points post 
transfection.  
Figure 3.19 Summary of cell proliferation assay in L-428 cells after transfection with 
pcDNA3.1(-) control vector, MSBI1.176 Rep WT OE protein and MSBI1.176 Rep Mut 
protein. A) representative EdU positive cells at 48h post transfection, B) percentage 
of EdU positive cells after 24h, 48h and 72h for all three conditions, C) western blot 
analysis suing anti-His Rep antibody and alpha tubulin as loading control. No 
difference was observed for the two genomes.  
Figure 3.20 Box plot analysis based on ELISA results. Comparison between 50 
Hodgkin’s Lymphoma serum samples, 30 breast cancer serum samples and 30 
plasma controls using Wild type (WT) Rep MSBI1.176 protein as antigen. 
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Figure 3.21 Box plot analysis based on ELISA results. Comparison between 50 
Hodgkin’s Lymphoma serum samples, 30 breast cancer serum samples and 30 
plasma controls using the EBNA1 protein as antigen.  
Figure 3.22 Box plot analysis based on ELISA results. Comparison between plasma 
controls from female and male donors using the Wild type (WT) Rep MSBI1.176 
protein as antigen. 
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